The PMP22 gene and its related diseases.

Molecular neurobiology

Volumn 47, Issue 2, 2013, Pages 673-698

  Li, Jun ^a   Parker, Brett ^b   Martyn, Colin ^b   Natarajan, Chandramohan ^b   Guo, Jiasong ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN; PMP22 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ANIMAL; GENETICS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; METABOLISM; MOLECULAR GENETICS; MUTATION; PATHOLOGY; PERIPHERAL NEUROPATHY; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CHARCOT-MARIE-TOOTH DISEASE; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; MYELIN PROTEINS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 84883137706     PISSN: None     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8370-x     Document Type: Review

References (227)

1. 1. JL Salzer 2003 Polarized domains of myelinated axons Neuron 40 297 318 14556710 1:CAS:528:DC%2BD3sXosFCqsro%3D 10.1016/S0896-6273(03)00628-7 Salzer JL (2003) Polarized domains of myelinated axons. Neuron 40:297–318
2. 2. DK Hartline DR Colman 2007 Rapid conduction and the evolution of giant axons and myelinated fibers Curr Biol 17 R29 R35 17208176 1:CAS:528:DC%2BD2sXis1alsw%3D%3D 10.1016/j.cub.2006.11.042 Hartline DK, Colman DR (2007) Rapid conduction and the evolution of giant axons and myelinated fibers. Curr Biol 17:R29–R35
3. 3. EJ Arroyo SS Scherer 2000 On the molecular architecture of myelinated fibers Histochem Cell Biol 113 1 18 10664064 1:CAS:528:DC%2BD3cXktFamsA%3D%3D 10.1007/s004180050001 Arroyo EJ, Scherer SS (2000) On the molecular architecture of myelinated fibers. Histochem Cell Biol 113:1–18
4. 4. SS Scherer EJ Arroyo 2002 Recent progress on the molecular organization of myelinated axons J Peripher Nerv Syst 7 1 12 11939347 1:CAS:528:DC%2BD38XjtFWjt7o%3D 10.1046/j.1529-8027.2002.02001.x Scherer SS, Arroyo EJ (2002) Recent progress on the molecular organization of myelinated axons. J Peripher Nerv Syst 7:1–12
5. 5. GJ Snipes U Suter AA Welcher EM Shooter 1992 Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13) J Cell Biol 117 225 238 1556154 1:CAS:528:DyaK38XhvFWlsbs%3D 10.1083/jcb.117.1.225 Snipes GJ, Suter U, Welcher AA, Shooter EM (1992) Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13). J Cell Biol 117:225–238
6. 6. AA Welcher LM De U Suter GJ Snipes SO Meakin EM Shooter 1992 Isolation of transcriptionally regulated sequences associated with neuronal and non-neuronal cell interactions Prog Brain Res 94 163 176 1287719 1:CAS:528:DyaK3sXhvVyrsL8%3D 10.1016/S0079-6123(08)61748-3 Welcher AA, De LM, Suter U, Snipes GJ, Meakin SO, Shooter EM (1992) Isolation of transcriptionally regulated sequences associated with neuronal and non-neuronal cell interactions. Prog Brain Res 94:163–176
7. 7. H Skre 1974 Genetic and clinical aspects of Charcot–Marie–Tooth's disease Clin Genet 6 98 118 4430158 1:STN:280:DyaE2M%2Fjsl2qtw%3D%3D 10.1111/j.1399-0004.1974.tb00638.x Skre H (1974) Genetic and clinical aspects of Charcot–Marie–Tooth's disease. Clin Genet 6:98–118
8. 8. C Schneider RM King L Philipson 1988 Genes specifically expressed at growth arrest of mammalian cells Cell 54 787 793 3409319 1:CAS:528:DyaL1MXit1Khurc%3D 10.1016/S0092-8674(88)91065-3 Schneider C, King RM, Philipson L (1988) Genes specifically expressed at growth arrest of mammalian cells. Cell 54:787–793
9. 9. G Manfioletti ME Ruaro SG Del L Philipson C Schneider 1990 A growth arrest-specific (gas) gene codes for a membrane protein Mol Cell Biol 10 2924 2930 1692961 1:CAS:528:DyaK3cXltFSht7k%3D Manfioletti G, Ruaro ME, Del SG, Philipson L, Schneider C (1990) A growth arrest-specific (gas) gene codes for a membrane protein. Mol Cell Biol 10:2924–2930
10. 10. K Kitamura M Suzuki K Uyemura 1976 Purification and partial characterization of two glycoproteins in bovine peripheral nerve myelin membrane Biochim Biophys Acta 455 806 816 999941 1:CAS:528:DyaE2sXjvV2jtQ%3D%3D 10.1016/0005-2736(76)90050-X Kitamura K, Suzuki M, Uyemura K (1976) Purification and partial characterization of two glycoproteins in bovine peripheral nerve myelin membrane. Biochim Biophys Acta 455:806–816
11. 11. AM Jetten U Suter 2000 The peripheral myelin protein 22 and epithelial membrane protein family Prog Nucleic Acid Res Mol Biol 64 97 129 10697408 1:CAS:528:DC%2BD3cXivVCns7c%3D 10.1016/S0079-6603(00)64003-5 Jetten AM, Suter U (2000) The peripheral myelin protein 22 and epithelial membrane protein family. Prog Nucleic Acid Res Mol Biol 64:97–129
12. 12. P Spreyer G Kuhn CO Hanemann C Gillen H Schaal R Kuhn G Lemke HW Muller 1991 Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth arrest-specific' gene EMBO J 10 3661 3668 1935894 1:CAS:528:DyaK3sXpvVynug%3D%3D Spreyer P, Kuhn G, Hanemann CO, Gillen C, Schaal H, Kuhn R, Lemke G, Muller HW (1991) Axon-regulated expression of a Schwann cell transcript that is homologous to a 'growth arrest-specific' gene. EMBO J 10:3661–3668
13. 13. van de Wetering RA, Gabreëls-Festen AA, Kremer H, Kalscheuer VM, Gabreëls FJ, Mariman EC (1999) Regulation and expression of the murine PMP22 gene. Mamm Genome 10:419–22
14. 14. U Suter PI Patel 1994 Genetic basis of inherited peripheral neuropathies Hum Mutat 3 95 102 7515304 1:CAS:528:DyaK2cXmslOmtbY%3D 10.1002/humu.1380030203 Suter U, Patel PI (1994) Genetic basis of inherited peripheral neuropathies. Hum Mutat 3:95–102
15. 15. Y Chen A Medvedev P Ruzanov KW Marvin AM Jetten 1997 cDNA cloning, genomic structure, and chromosome mapping of the human epithelial membrane protein CL-20 gene (EMP1), a member of the PMP22 family Genomics 41 40 48 9126480 1:CAS:528:DyaK2sXitlyqtLk%3D 10.1006/geno.1997.4524 Chen Y, Medvedev A, Ruzanov P, Marvin KW, Jetten AM (1997) cDNA cloning, genomic structure, and chromosome mapping of the human epithelial membrane protein CL-20 gene (EMP1), a member of the PMP22 family. Genomics 41:40–48
16. 16. Y Ohsawa T Murakami Y Miyazaki T Shirabe Y Sunada 2006 Peripheral myelin protein 22 is expressed in human central nervous system J Neurol Sci 247 11 15 16626749 1:CAS:528:DC%2BD28Xns1Kitbw%3D 10.1016/j.jns.2006.03.004 Ohsawa Y, Murakami T, Miyazaki Y, Shirabe T, Sunada Y (2006) Peripheral myelin protein 22 is expressed in human central nervous system. J Neurol Sci 247:11–15
17. 17. KJ Roux SA Amici L Notterpek 2004 The temporospatial expression of peripheral myelin protein 22 at the developing blood–nerve and blood–brain barriers J Comp Neurol 474 578 588 15174074 1:CAS:528:DC%2BD2cXlsVCls7Y%3D 10.1002/cne.20154 Roux KJ, Amici SA, Notterpek L (2004) The temporospatial expression of peripheral myelin protein 22 at the developing blood–nerve and blood–brain barriers. J Comp Neurol 474:578–588
18. 18. E Parmantier F Cabon C Braun D D'Urso HW Muller B Zalc 1995 Peripheral myelin protein-22 is expressed in rat and mouse brain and spinal cord motoneurons Eur J Neurosci 7 1080 1088 7613613 1:STN:280:DyaK2MzjvVeiug%3D%3D 10.1111/j.1460-9568.1995.tb01095.x Parmantier E, Cabon F, Braun C, D'Urso D, Muller HW, Zalc B (1995) Peripheral myelin protein-22 is expressed in rat and mouse brain and spinal cord motoneurons. Eur J Neurosci 7:1080–1088
19. 19. V Taylor AA Welcher AE Program U Suter 1995 Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family J Biol Chem 270 28824 28833 7499407 1:CAS:528:DyaK2MXpslOjtLw%3D 10.1074/jbc.270.48.28824 Taylor V, Welcher AA, Program AE, Suter U (1995) Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family. J Biol Chem 270:28824–28833
20. 20. De León M, Nahin RL, Mendoza ME, Ruda MA (1994) SR13/PMP-22 expression in rat nervous system, in PC12 cells, and C6 glial cell lines. J Neurosci Res 38:167–81
21. 21. Wulf P, Suter U (1999) Embryonic expression of epithelial membrane protein 1 in early neurons. Brain Res Dev Brain Res 116(2):169–80
22. 22. E Parmantier C Braun JL Thomas F Peyron S Martinez B Zalc 1997 PMP-22 expression in the central nervous system of the embryonic mouse defines potential transverse segments and longitudinal columns J Comp Neurol 378 159 172 9120057 1:CAS:528:DyaK2sXhsVOjuro%3D 10.1002/(SICI)1096-9861(19970210)378:2<159::AID-CNE1>3.0.CO;2-2 Parmantier E, Braun C, Thomas JL, Peyron F, Martinez S, Zalc B (1997) PMP-22 expression in the central nervous system of the embryonic mouse defines potential transverse segments and longitudinal columns. J Comp Neurol 378:159–172
23. 23. CS Lobsiger JP Magyar V Taylor P Wulf AA Welcher AE Program U Suter 1996 Identification and characterization of a cDNA and the structural gene encoding the mouse epithelial membrane protein-1 Genomics 36 379 387 8884260 1:CAS:528:DyaK28XlvFWrt7o%3D 10.1006/geno.1996.0482 Lobsiger CS, Magyar JP, Taylor V, Wulf P, Welcher AA, Program AE, Suter U (1996) Identification and characterization of a cDNA and the structural gene encoding the mouse epithelial membrane protein-1. Genomics 36:379–387
24. 24. Baechner D, Liehr T, Hameister H, Altenberger H, Grehl H, Suter U, Rautenstrauss B (1995) Widespread expression of the peripheral myelin protein-22 gene (PMP22) in neural and non-neural tissues during murine development. J Neurosci Res 42:733–41
25. 25. Erne B, Sansano S, Frank M, Schaeren-Wiemers N (2002) Rafts in adult peripheral nerve myelin contain major structural myelin proteins and myelin and lymphocyte protein (MAL) and CD59 as specific markers. J Neurochem 82:550–62
26. 27. D'Urso D, Müller HW (1997) Ins and outs of peripheral myelin protein-22: mapping transmembrane topology and intracellular sorting. J Neurosci Res 49:551–62
27. 28. L Notterpek KJ Roux SA Amici A Yazdanpour C Rahner BS Fletcher 2001 Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia Proc Natl Acad Sci U S A 98 14404 14409 11717414 1:CAS:528:DC%2BD3MXptFCltL0%3D 10.1073/pnas.251548398 Notterpek L, Roux KJ, Amici SA, Yazdanpour A, Rahner C, Fletcher BS (2001) Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia. Proc Natl Acad Sci U S A 98:14404–14409
28. 29. L Notterpek EM Shooter GJ Snipes 1997 Upregulation of the endosomal–lysosomal pathway in the trembler-J neuropathy J Neurosci 17 4190 4200 9151736 1:CAS:528:DyaK2sXjtlKmtLo%3D Notterpek L, Shooter EM, Snipes GJ (1997) Upregulation of the endosomal–lysosomal pathway in the trembler-J neuropathy. J Neurosci 17:4190–4200
29. 30. Haney C, Snipes GJ, Shooter EM, Suter U, Garcia C, Griffin JW, Trapp BD (1996) Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A. J Neuropathol Exp Neurol 55:290–9
30. 31. Carenini S, Neuberg D, Schachner M, Suter U, Martini R (1999) Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice. Glia 28:256–64
31. 32. LM De RL Nahin ME Mendoza MA Ruda 1994 SR13/PMP-22 expression in rat nervous system, in PC12 cells, and C6 glial cell lines J Neurosci Res 38 167 181 10.1002/jnr.490380207 De LM, Nahin RL, Mendoza ME, Ruda MA (1994) SR13/PMP-22 expression in rat nervous system, in PC12 cells, and C6 glial cell lines. J Neurosci Res 38:167–181
32. 33. V Taylor C Zgraggen R Naef U Suter 2000 Membrane topology of peripheral myelin protein 22 J Neurosci Res 62 15 27 11002284 1:CAS:528:DC%2BD3cXnsVSgtLc%3D 10.1002/1097-4547(20001001)62:1<15::AID-JNR3>3.0.CO;2-F Taylor V, Zgraggen C, Naef R, Suter U (2000) Membrane topology of peripheral myelin protein 22. J Neurosci Res 62:15–27
33. 34. S Pareek U Suter GJ Snipes AA Welcher EM Shooter RA Murphy 1993 Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells J Biol Chem 268 10372 10379 8486695 1:CAS:528:DyaK3sXktVGmurs%3D Pareek S, Suter U, Snipes GJ, Welcher AA, Shooter EM, Murphy RA (1993) Detection and processing of peripheral myelin protein PMP22 in cultured Schwann cells. J Biol Chem 268:10372–10379
34. 35. D D'Urso R Prior R Greiner-Petter AA Gabreels-Festen HW Muller 1998 Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22 J Neurosci 18 731 740 9425015 D'Urso D, Prior R, Greiner-Petter R, Gabreels-Festen AA, Muller HW (1998) Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22. J Neurosci 18:731–740
35. 36. B Hasse F Bosse H Hanenberg HW Muller 2004 Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions Mol Cell Neurosci 27 370 378 15555916 1:CAS:528:DC%2BD2cXhtVSntr7M 10.1016/j.mcn.2004.06.009 Hasse B, Bosse F, Hanenberg H, Muller HW (2004) Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions. Mol Cell Neurosci 27:370–378
36. 37. J Sedzik Y Kotake K Uyemura 1998 Purification of PASII/PMP22—an extremely hydrophobic glycoprotein of PNS myelin membrane Neuroreport 9 1595 1600 9631472 1:CAS:528:DyaK1cXktV2mu7Y%3D 10.1097/00001756-199805110-00062 Sedzik J, Kotake Y, Uyemura K (1998) Purification of PASII/PMP22—an extremely hydrophobic glycoprotein of PNS myelin membrane. Neuroreport 9:1595–1600
37. 38. J Sedzik T Tsukihara 2000 Solubilization of PNS myelin membrane proteins by detergents Neuroreport 11 2559 2563 10943722 1:CAS:528:DC%2BD3cXlvFyntLw%3D 10.1097/00001756-200008030-00042 Sedzik J, Tsukihara T (2000) Solubilization of PNS myelin membrane proteins by detergents. Neuroreport 11:2559–2563
38. 39. J Sedzik K Uyemura T Tsukihara 2002 Towards crystallization of hydrophobic myelin glycoproteins: P0 and PASII/PMP22 Protein Expr Purif 26 368 377 12460760 1:CAS:528:DC%2BD38Xps1Whtb8%3D 10.1016/S1046-5928(02)00564-8 Sedzik J, Uyemura K, Tsukihara T (2002) Towards crystallization of hydrophobic myelin glycoproteins: P0 and PASII/PMP22. Protein Expr Purif 26:368–377
39. 40. CK Mobley JK Myers A Hadziselimovic CD Ellis CR Sanders 2007 Purification and initiation of structural characterization of human peripheral myelin protein 22, an integral membrane protein linked to peripheral neuropathies Biochemistry 46 11185 11195 17824619 1:CAS:528:DC%2BD2sXpvFOiur0%3D 10.1021/bi700855j Mobley CK, Myers JK, Hadziselimovic A, Ellis CD, Sanders CR (2007) Purification and initiation of structural characterization of human peripheral myelin protein 22, an integral membrane protein linked to peripheral neuropathies. Biochemistry 46:11185–11195
40. 41. M Sakakura A Hadziselimovic Z Wang KL Schey CR Sanders 2011 Structural basis for the Trembler-J phenotype of Charcot–Marie–Tooth disease Structure 19 1160 1169 21827951 1:CAS:528:DC%2BC3MXpvFWktbw%3D 10.1016/j.str.2011.05.009 Sakakura M, Hadziselimovic A, Wang Z, Schey KL, Sanders CR (2011) Structural basis for the Trembler-J phenotype of Charcot–Marie–Tooth disease. Structure 19:1160–1169
41. 42. JK Myers CK Mobley CR Sanders 2008 The peripheral neuropathy-linked Trembler and Trembler-J mutant forms of peripheral myelin protein 22 are folding-destabilized Biochemistry 47 10620 10629 18795802 1:CAS:528:DC%2BD1cXhtFWksLjF 10.1021/bi801157p Myers JK, Mobley CK, Sanders CR (2008) The peripheral neuropathy-linked Trembler and Trembler-J mutant forms of peripheral myelin protein 22 are folding-destabilized. Biochemistry 47:10620–10629
42. 43. M Maier P Berger KA Nave U Suter 2002 Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves Mol Cell Neurosci 20 93 109 12056842 1:CAS:528:DC%2BD38Xktlyltbs%3D 10.1006/mcne.2002.1116 Maier M, Berger P, Nave KA, Suter U (2002) Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves. Mol Cell Neurosci 20:93–109
43. 44. M Maier F Castagner P Berger U Suter 2003 Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons Mol Cell Neurosci 24 803 817 14664827 1:CAS:528:DC%2BD3sXps1eqt7w%3D 10.1016/S1044-7431(03)00246-X Maier M, Castagner F, Berger P, Suter U (2003) Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons. Mol Cell Neurosci 24:803–817
44. 45. D Saberan-Djoneidi V Sanguedolce Z Assouline N Levy E Passage M Fontes 2000 Molecular dissection of the Schwann cell specific promoter of the PMP22 gene Gene 248 223 231 10806367 1:CAS:528:DC%2BD3cXjtVajsro%3D 10.1016/S0378-1119(00)00116-5 Saberan-Djoneidi D, Sanguedolce V, Assouline Z, Levy N, Passage E, Fontes M (2000) Molecular dissection of the Schwann cell specific promoter of the PMP22 gene. Gene 248:223–231
45. 46. M Hai SI Bidichandani PI Patel 2001 Identification of a positive regulatory element in the myelin-specific promoter of the PMP22 gene J Neurosci Res 65 508 519 11550219 1:CAS:528:DC%2BD3MXnt12gsrg%3D 10.1002/jnr.1181 Hai M, Bidichandani SI, Patel PI (2001) Identification of a positive regulatory element in the myelin-specific promoter of the PMP22 gene. J Neurosci Res 65:508–519
46. 47. W Orfali RN Nicholson MC Guiot AC Peterson GJ Snipes 2005 An 8.5-kb segment of the PMP22 promoter responds to loss of axon signals during Wallerian degeneration, but does not respond to specific axonal signals during nerve regeneration J Neurosci Res 80 37 46 15723356 1:CAS:528:DC%2BD2MXjtlSnu7Y%3D 10.1002/jnr.20425 Orfali W, Nicholson RN, Guiot MC, Peterson AC, Snipes GJ (2005) An 8.5-kb segment of the PMP22 promoter responds to loss of axon signals during Wallerian degeneration, but does not respond to specific axonal signals during nerve regeneration. J Neurosci Res 80:37–46
47. 48. E Passage JC Norreel P Noack-Fraissignes V Sanguedolce J Pizant X Thirion A Robaglia-Schlupp JF Pellissier M Fontes 2004 Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot–Marie–Tooth disease Nat Med 10 396 401 15034573 1:CAS:528:DC%2BD2cXis1ektLs%3D 10.1038/nm1023 Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, Robaglia-Schlupp A, Pellissier JF, Fontes M (2004) Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot–Marie–Tooth disease. Nat Med 10:396–401
48. 49. F Desarnaud AN Do Thi AM Brown G Lemke U Suter EE Baulieu M Schumacher 1998 Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells J Neurochem 71 1765 1768 9751213 1:CAS:528:DyaK1cXmt1Kitb8%3D 10.1046/j.1471-4159.1998.71041765.x Desarnaud F, Do Thi AN, Brown AM, Lemke G, Suter U, Baulieu EE, Schumacher M (1998) Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. J Neurochem 71:1765–1768
49. 50. F Desarnaud S Bidichandani PI Patel EE Baulieu M Schumacher 2000 Glucocorticosteroids stimulate the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells Brain Res 865 12 16 10814728 1:CAS:528:DC%2BD3cXjt1aquro%3D 10.1016/S0006-8993(00)02130-2 Desarnaud F, Bidichandani S, Patel PI, Baulieu EE, Schumacher M (2000) Glucocorticosteroids stimulate the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells. Brain Res 865:12–16
50. 51. KR Monk SG Naylor TD Glenn S Mercurio JR Perlin C Dominguez CB Moens WS Talbot 2009 A G protein-coupled receptor is essential for Schwann cells to initiate myelination Science 325 1402 1405 19745155 1:CAS:528:DC%2BD1MXhtV2ltbnP 10.1126/science.1173474 Monk KR, Naylor SG, Glenn TD, Mercurio S, Perlin JR, Dominguez C, Moens CB, Talbot WS (2009) A G protein-coupled receptor is essential for Schwann cells to initiate myelination. Science 325:1402–1405
51. 52. KR Monk K Oshima S Jors S Heller WS Talbot 2011 Gpr126 is essential for peripheral nerve development and myelination in mammals Development 138 2673 2680 21613327 1:CAS:528:DC%2BC3MXpvFeksbo%3D 10.1242/dev.062224 Monk KR, Oshima K, Jors S, Heller S, Talbot WS (2011) Gpr126 is essential for peripheral nerve development and myelination in mammals. Development 138:2673–2680
52. 53. J Ghislain C Desmarquet-Trin-Dinh P Gilardi-Hebenstreit P Charnay M Frain 2003 Neural crest patterning: autoregulatory and crest-specific elements co-operate for Krox20 transcriptional control Development 130 941 953 12538520 1:CAS:528:DC%2BD3sXisVeltL8%3D 10.1242/dev.00318 Ghislain J, Desmarquet-Trin-Dinh C, Gilardi-Hebenstreit P, Charnay P, Frain M (2003) Neural crest patterning: autoregulatory and crest-specific elements co-operate for Krox20 transcriptional control. Development 130:941–953
53. 54. TS Zorick DE Syroid A Brown T Gridley G Lemke 1999 Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells Development 126 1397 1406 10068633 1:CAS:528:DyaK1MXivVekur4%3D Zorick TS, Syroid DE, Brown A, Gridley T, Lemke G (1999) Krox-20 controls SCIP expression, cell cycle exit and susceptibility to apoptosis in developing myelinating Schwann cells. Development 126:1397–1406
54. 55. J Ghislain C Desmarquet-Trin-Dinh M Jaegle D Meijer P Charnay M Frain 2002 Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development Development 129 155 166 11782409 1:CAS:528:DC%2BD38XovVaitQ%3D%3D Ghislain J, Desmarquet-Trin-Dinh C, Jaegle M, Meijer D, Charnay P, Frain M (2002) Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development. Development 129:155–166
55. 56. S Reiprich J Kriesch S Schreiner M Wegner 2010 Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells J Neurochem 112 744 754 19922439 1:CAS:528:DC%2BC3cXht1erur8%3D 10.1111/j.1471-4159.2009.06498.x Reiprich S, Kriesch J, Schreiner S, Wegner M (2010) Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells. J Neurochem 112:744–754
56. 57. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, Babinet C, Charnay P (1994) Krox-20 controls myelination in the peripheral nervous system. Nature 371:796–799
57. 58. E Bellone ME Di S Soriani A Varese LL Doria F Ajmar P Mandich 1999 A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot–Marie–Tooth type 1 disease Hum Mutat 14 353 354 10502832 1:STN:280:DyaK1MvjsVeksg%3D%3D 10.1002/(SICI)1098-1004(199910)14:4<353::AID-HUMU17>3.0.CO;2-4 Bellone E, Di ME, Soriani S, Varese A, Doria LL, Ajmar F, Mandich P (1999) A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot–Marie–Tooth type 1 disease. Hum Mutat 14:353–354
58. 59. V Timmerman P Jonghe De C Ceuterick E Vriendt De A Lofgren E Nelis LE Warner JR Lupski JJ Martin C Broeckhoven Van 1999 Novel missense mutation in the early growth response 2 gene associated with Dejerine–Sottas syndrome phenotype Neurology 52 1827 1832 10371530 1:CAS:528:DyaK1MXktVeju7c%3D 10.1212/WNL.52.9.1827 Timmerman V, De Jonghe P, Ceuterick C, De Vriendt E, Lofgren A, Nelis E, Warner LE, Lupski JR, Martin JJ, Van Broeckhoven C (1999) Novel missense mutation in the early growth response 2 gene associated with Dejerine–Sottas syndrome phenotype. Neurology 52:1827–1832
59. 60. LE Warner P Mancias IJ Butler CM McDonald L Keppen KG Koob JR Lupski 1998 Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies Nat Genet 18 382 384 9537424 1:CAS:528:DyaK1cXit1egs7o%3D 10.1038/ng0498-382 Warner LE, Mancias P, Butler IJ, McDonald CM, Keppen L, Koob KG, Lupski JR (1998) Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet 18:382–384
60. 61. LE Warner J Svaren J Milbrandt JR Lupski 1999 Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies Hum Mol Genet 8 1245 1251 10369870 1:CAS:528:DyaK1MXkslSlsbw%3D 10.1093/hmg/8.7.1245 Warner LE, Svaren J, Milbrandt J, Lupski JR (1999) Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Hum Mol Genet 8:1245–1251
61. 62. R Nagarajan J Svaren N Le T Araki M Watson J Milbrandt 2001 EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression Neuron 30 355 368 11394999 1:CAS:528:DC%2BD3MXktFeitr4%3D 10.1016/S0896-6273(01)00282-3 Nagarajan R, Svaren J, Le N, Araki T, Watson M, Milbrandt J (2001) EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 30:355–368
62. 63. N Bondurand M Girard V Pingault N Lemort O Dubourg M Goossens 2001 Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot–Marie–Tooth disease, is directly regulated by the transcription factor SOX10 Hum Mol Genet 10 2783 2795 11734543 1:CAS:528:DC%2BD3MXptlKrsLY%3D 10.1093/hmg/10.24.2783 Bondurand N, Girard M, Pingault V, Lemort N, Dubourg O, Goossens M (2001) Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot–Marie–Tooth disease, is directly regulated by the transcription factor SOX10. Hum Mol Genet 10:2783–2795
63. 64. SW Jang R Srinivasan EA Jones G Sun S Keles C Krueger LW Chang R Nagarajan J Svaren 2010 Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes J Neurochem 115 1409 1420 21044070 1:CAS:528:DC%2BC3cXhs1aiurrM 10.1111/j.1471-4159.2010.07045.x Jang SW, Srinivasan R, Jones EA, Sun G, Keles S, Krueger C, Chang LW, Nagarajan R, Svaren J (2010) Locus-wide identification of Egr2/Krox20 regulatory targets in myelin genes. J Neurochem 115:1409–1420
64. 65. SE LeBlanc RM Ward J Svaren 2007 Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10 Mol Cell Biol 27 3521 3529 17325040 1:CAS:528:DC%2BD2sXltFCksbk%3D 10.1128/MCB.01689-06 LeBlanc SE, Ward RM, Svaren J (2007) Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10. Mol Cell Biol 27:3521–3529
65. 66. SE LeBlanc SW Jang RM Ward L Wrabetz J Svaren 2006 Direct regulation of myelin protein zero expression by the Egr2 transactivator J Biol Chem 281 5453 5460 16373334 1:CAS:528:DC%2BD28XhvVejsbw%3D 10.1074/jbc.M512159200 LeBlanc SE, Jang SW, Ward RM, Wrabetz L, Svaren J (2006) Direct regulation of myelin protein zero expression by the Egr2 transactivator. J Biol Chem 281:5453–5460
66. 67. EA Jones SW Jang GM Mager LW Chang R Srinivasan NG Gokey RM Ward R Nagarajan J Svaren 2007 Interactions of Sox10 and Egr2 in myelin gene regulation Neuron Glia Biol 3 377 387 18634568 10.1017/S1740925X08000173 Jones EA, Jang SW, Mager GM, Chang LW, Srinivasan R, Gokey NG, Ward RM, Nagarajan R, Svaren J (2007) Interactions of Sox10 and Egr2 in myelin gene regulation. Neuron Glia Biol 3:377–387
67. 68. EA Jones MH Brewer R Srinivasan C Krueger G Sun KN Charney S Keles A Antonellis J Svaren 2012 Distal enhancers upstream of the Charcot–Marie–Tooth type 1A disease gene PMP22 Hum Mol Genet 21 1581 1591 22180461 1:CAS:528:DC%2BC38Xjs1Srtb8%3D 10.1093/hmg/ddr595 Jones EA, Brewer MH, Srinivasan R, Krueger C, Sun G, Charney KN, Keles S, Antonellis A, Svaren J (2012) Distal enhancers upstream of the Charcot–Marie–Tooth type 1A disease gene PMP22. Hum Mol Genet 21:1581–1591
68. 69. EA Jones C Lopez-Anido R Srinivasan C Krueger LW Chang R Nagarajan J Svaren 2011 Regulation of the PMP22 gene through an intronic enhancer J Neurosci 31 4242 4250 21411665 1:CAS:528:DC%2BC3MXjvFWmtbY%3D 10.1523/JNEUROSCI.5893-10.2011 Jones EA, Lopez-Anido C, Srinivasan R, Krueger C, Chang LW, Nagarajan R, Svaren J (2011) Regulation of the PMP22 gene through an intronic enhancer. J Neurosci 31:4242–4250
69. 70. MA Weterman F Ruissen van M Wissel de L Bordewijk JP Samijn WL Pol van der F Meggouh F Baas 2010 Copy number variation upstream of PMP22 in Charcot–Marie–Tooth disease Eur J Hum Genet 18 421 428 19888301 1:CAS:528:DC%2BC3cXjsFCrs74%3D 10.1038/ejhg.2009.186 Weterman MA, van Ruissen F, de Wissel M, Bordewijk L, Samijn JP, van der Pol WL, Meggouh F, Baas F (2010) Copy number variation upstream of PMP22 in Charcot–Marie–Tooth disease. Eur J Hum Genet 18:421–428
70. 71. F Zhang P Seeman P Liu MA Weterman C Gonzaga-Jauregui CF Towne SD Batish VE De JP De B Rautenstrauss KH Krause M Khajavi J Posadka A Vandenberghe F Palau ML Van F Baas V Timmerman JR Lupski 2010 Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability Am J Hum Genet 86 892 903 20493460 1:CAS:528:DC%2BC3cXot1CgtrY%3D 10.1016/j.ajhg.2010.05.001 Zhang F, Seeman P, Liu P, Weterman MA, Gonzaga-Jauregui C, Towne CF, Batish SD, De VE, De JP, Rautenstrauss B, Krause KH, Khajavi M, Posadka J, Vandenberghe A, Palau F, Van ML, Baas F, Timmerman V, Lupski JR (2010) Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: rare CNVs as a cause for missing heritability. Am J Hum Genet 86:892–903
71. 72. SE LeBlanc R Srinivasan C Ferri GM Mager AL Gillian-Daniel L Wrabetz J Svaren 2005 Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination J Neurochem 93 737 748 15836632 1:CAS:528:DC%2BD2MXktFKgu74%3D 10.1111/j.1471-4159.2005.03056.x LeBlanc SE, Srinivasan R, Ferri C, Mager GM, Gillian-Daniel AL, Wrabetz L, Svaren J (2005) Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination. J Neurochem 93:737–748
72. 73. WJ Ingram CA Wicking SM Grimmond AR Forrest BJ Wainwright 2002 Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells Oncogene 21 8196 8205 12444557 1:CAS:528:DC%2BD38XovVWiuro%3D 10.1038/sj.onc.1205975 Ingram WJ, Wicking CA, Grimmond SM, Forrest AR, Wainwright BJ (2002) Novel genes regulated by Sonic Hedgehog in pluripotent mesenchymal cells. Oncogene 21:8196–8205
73. 74. F Bosse J Brodbeck HW Muller 1999 Post-transcriptional regulation of the peripheral myelin protein gene PMP22/gas3 J Neurosci Res 55 164 177 9972819 1:CAS:528:DyaK1MXnslaiug%3D%3D 10.1002/(SICI)1097-4547(19990115)55:2<164::AID-JNR4>3.0.CO;2-9 Bosse F, Brodbeck J, Muller HW (1999) Post-transcriptional regulation of the peripheral myelin protein gene PMP22/gas3. J Neurosci Res 55:164–177
74. 75. F Bosse G Zoidl S Wilms CP Gillen HG Kuhn HW Muller 1994 Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination J Neurosci Res 37 529 537 8021974 1:CAS:528:DyaK2cXivFWhu78%3D 10.1002/jnr.490370412 Bosse F, Zoidl G, Wilms S, Gillen CP, Kuhn HG, Muller HW (1994) Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination. J Neurosci Res 37:529–537
75. 76. MC Ryan L Notterpek AR Tobler N Liu EM Shooter 2000 Role of the peripheral myelin protein 22 N-linked glycan in oligomer stability J Neurochem 75 1465 1474 10987826 1:CAS:528:DC%2BD3cXmslGltr0%3D 10.1046/j.1471-4159.2000.0751465.x Ryan MC, Notterpek L, Tobler AR, Liu N, Shooter EM (2000) Role of the peripheral myelin protein 22 N-linked glycan in oligomer stability. J Neurochem 75:1465–1474
76. 77. N Liu J Yamauchi EM Shooter 2004 Recessive, but not dominant, mutations in peripheral myelin protein 22 gene show unique patterns of aggregation and intracellular trafficking Neurobiol Dis 17 300 309 15474367 1:CAS:528:DC%2BD2cXotlSltro%3D 10.1016/j.nbd.2004.07.010 Liu N, Yamauchi J, Shooter EM (2004) Recessive, but not dominant, mutations in peripheral myelin protein 22 gene show unique patterns of aggregation and intracellular trafficking. Neurobiol Dis 17:300–309
77. 78. AR Tobler L Notterpek R Naef V Taylor U Suter EM Shooter 1999 Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction J Neurosci 19 2027 2036 10066256 1:CAS:528:DyaK1MXhslKmtr0%3D Tobler AR, Notterpek L, Naef R, Taylor V, Suter U, Shooter EM (1999) Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction. J Neurosci 19:2027–2036
78. 79. I Shames A Fraser J Colby W Orfali GJ Snipes 2003 Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot–Marie–Tooth-related diseases J Neuropathol Exp Neurol 62 751 764 12901701 1:CAS:528:DC%2BD3sXmsFCntb4%3D Shames I, Fraser A, Colby J, Orfali W, Snipes GJ (2003) Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot–Marie–Tooth-related diseases. J Neuropathol Exp Neurol 62:751–764
79. 80. R Naef K Adlkofer B Lescher U Suter 1997 Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies Mol Cell Neurosci 9 13 25 9204477 1:CAS:528:DyaK2sXjslent7g%3D 10.1006/mcne.1997.0604 Naef R, Adlkofer K, Lescher B, Suter U (1997) Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies. Mol Cell Neurosci 9:13–25
80. 81. J Colby R Nicholson KM Dickson W Orfali R Naef U Suter GJ Snipes 2000 PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells Neurobiol Dis 7 561 573 11114256 1:CAS:528:DC%2BD3cXoslSms7c%3D 10.1006/nbdi.2000.0323 Colby J, Nicholson R, Dickson KM, Orfali W, Naef R, Suter U, Snipes GJ (2000) PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells. Neurobiol Dis 7:561–573
81. 82. S Pareek L Notterpek GJ Snipes R Naef W Sossin J Laliberte S Iacampo U Suter EM Shooter RA Murphy 1997 Neurons promote the translocation of peripheral myelin protein 22 into myelin J Neurosci 17 7754 7762 9315897 1:CAS:528:DyaK2sXms1egtbg%3D Pareek S, Notterpek L, Snipes GJ, Naef R, Sossin W, Laliberte J, Iacampo S, Suter U, Shooter EM, Murphy RA (1997) Neurons promote the translocation of peripheral myelin protein 22 into myelin. J Neurosci 17:7754–7762
82. 83. G Zoidl S Blass-Kampmann D D'Urso C Schmalenbach HW Müller 1995 Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth EMBO J 14 6 1122 1128 7720703 1:CAS:528:DyaK2MXlsFSnsr4%3D Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C, Müller HW (1995) Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J 14(6):1122–1128
83. 84. D D'Urso C Schmalenbach G Zoidl R Prior HW Müller 1997 Studies on the effects of altered PMP22 expression during myelination in vitro J Neurosci Res 48 1 31 42 9086179 10.1002/(SICI)1097-4547(19970401)48:1<31::AID-JNR3>3.0.CO;2-F D'Urso D, Schmalenbach C, Zoidl G, Prior R, Müller HW (1997) Studies on the effects of altered PMP22 expression during myelination in vitro. J Neurosci Res 48(1):31–42
84. 85. Hanemann CO, Rosenbaum C, Kupfer S, Wosch S, Stoegbauer F, Müller HW (1998 Jun) Improved culture methods to expand Schwann cells with altered growth behaviour from CMT1A patients. Glia 23(2):89–98
85. 86. L Nobbio T Vigo M Abbruzzese G Levi C Brancolini S Mantero M Grandis L Benedetti G Mancardi A Schenone 2004 Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot–Marie–Tooth type 1A disease Neurobiol Dis 16 263 273 15207283 1:CAS:528:DC%2BD2cXjs1alurk%3D 10.1016/j.nbd.2004.02.007 Nobbio L, Vigo T, Abbruzzese M, Levi G, Brancolini C, Mantero S, Grandis M, Benedetti L, Mancardi G, Schenone A (2004) Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot–Marie–Tooth type 1A disease. Neurobiol Dis 16:263–273
86. 87. S Erdem JR Mendell Z Sahenk 1998 Fate of Schwann cells in CMT1A and HNPP: evidence for apoptosis J Neuropathol Exp Neurol 57 6 635 642 9630241 1:STN:280:DyaK1c3pt1Wqtw%3D%3D 10.1097/00005072-199806000-00009 Erdem S, Mendell JR, Sahenk Z (1998) Fate of Schwann cells in CMT1A and HNPP: evidence for apoptosis. J Neuropathol Exp Neurol 57(6):635–642
87. 88. S Sancho P Young U Suter 2001 Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot–Marie––Tooth disease type 1A Brain 124 Pt 11 2177 2187 11673320 1:STN:280:DC%2BD3Mrms12jug%3D%3D 10.1093/brain/124.11.2177 Sancho S, Young P, Suter U (2001) Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot–Marie––Tooth disease type 1A. Brain 124(Pt 11):2177–2187
88. 89. CO Hanemann AA Gabreëls-Festen G Stoll HW Müller 1997 Schwann cell differentiation in Charcot–Marie–Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs Acta Neuropathol 94 4 310 315 9341930 1:CAS:528:DyaK2sXlvFCnurc%3D 10.1007/s004010050712 Hanemann CO, Gabreëls-Festen AA, Stoll G, Müller HW (1997) Schwann cell differentiation in Charcot–Marie–Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs. Acta Neuropathol 94(4):310–315
89. 90. G Zoidl D D'Urso S Blass-Kampmann C Schmalenbach R Kuhn HW Müller 1997 Influence of elevated expression of rat wild-type PMP22 and its mutant PMP22Trembler on cell growth of NIH3T3 fibroblasts Cell Tissue Res 287 3 459 470 9023077 1:CAS:528:DyaK2sXhslaisL4%3D 10.1007/s004410050770 Zoidl G, D'Urso D, Blass-Kampmann S, Schmalenbach C, Kuhn R, Müller HW (1997) Influence of elevated expression of rat wild-type PMP22 and its mutant PMP22Trembler on cell growth of NIH3T3 fibroblasts. Cell Tissue Res 287(3):459–470
90. 91. SA Amici WA Dunn Jr AJ Murphy NC Adams NW Gale DM Valenzuela GD Yancopoulos L Notterpek 2006 Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina J Neurosci 26 4 1179 1189 16436605 1:CAS:528:DC%2BD28XhsVSjsbk%3D 10.1523/JNEUROSCI.2618-05.2006 Amici SA, Dunn WA Jr, Murphy AJ, Adams NC, Gale NW, Valenzuela DM, Yancopoulos GD, Notterpek L (2006) Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina. J Neurosci 26(4):1179–1189
91. 92. CS Perkins AJ Aguayo GM Bray 1981 Schwann cell multiplication in Trembler mice Neuropathol Appl Neurobiol 7 2 115 126 7231639 1:STN:280:DyaL3M7pslyhtg%3D%3D 10.1111/j.1365-2990.1981.tb00081.x Perkins CS, Aguayo AJ, Bray GM (1981) Schwann cell multiplication in Trembler mice. Neuropathol Appl Neurobiol 7(2):115–126
92. 93. AM Robertson J Perea A McGuigan RH King JR Muddle AA Gabreels-Festen PK Thomas C Huxley 2002 Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A J Anat 200 4 377 390 12090404 1:STN:280:DC%2BD38zkslKnsQ%3D%3D 10.1046/j.1469-7580.2002.00039.x Robertson AM, Perea J, McGuigan A, King RH, Muddle JR, Gabreels-Festen AA, Thomas PK, Huxley C (2002) Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A. J Anat 200(4):377–390
93. 94. E Fabbretti P Edomi C Brancolini C Schneider 1995 Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A Genes Dev 9 15 1846 1856 7649472 1:CAS:528:DyaK2MXns1aqtLc%3D 10.1101/gad.9.15.1846 Fabbretti E, Edomi P, Brancolini C, Schneider C (1995) Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev 9(15):1846–1856
94. 95. C Brancolini P Edomi S Marzinotto C Schneider 2000 Exposure at the cell surface is required for gas3/PMP22 to regulate both cell death and cell spreading: implication for the Charcot–Marie–Tooth type 1A and Dejerine–Sottas diseases Mol Biol Cell 11 9 2901 2914 10982389 1:CAS:528:DC%2BD3cXmvFSiurg%3D Brancolini C, Edomi P, Marzinotto S, Schneider C (2000) Exposure at the cell surface is required for gas3/PMP22 to regulate both cell death and cell spreading: implication for the Charcot–Marie–Tooth type 1A and Dejerine–Sottas diseases. Mol Biol Cell 11(9):2901–2914
95. 96. C Brancolini S Marzinotto P Edomi E Agostoni C Fiorentini HW Müller C Schneider 1999 Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22 Mol Biol Cell 10 7 2441 2459 10397775 1:CAS:528:DyaK1MXks1Kmsbw%3D Brancolini C, Marzinotto S, Edomi P, Agostoni E, Fiorentini C, Müller HW, Schneider C (1999) Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. Mol Biol Cell 10(7):2441–2459
96. 97. JG Suh N Ichihara K Saigoh O Nakabayashi T Yamanishi K Tanaka K Wada T Kikuchi 1997 An in-frame deletion in peripheral myelin protein-22 gene causes hypomyelination and cell death of the Schwann cells in the new Trembler mutant mice Neuroscience 79 735 744 9219937 1:CAS:528:DyaK2sXktlWnt70%3D 10.1016/S0306-4522(96)00692-6 Suh JG, Ichihara N, Saigoh K, Nakabayashi O, Yamanishi T, Tanaka K, Wada K, Kikuchi T (1997) An in-frame deletion in peripheral myelin protein-22 gene causes hypomyelination and cell death of the Schwann cells in the new Trembler mutant mice. Neuroscience 79:735–744
97. 98. GJ Snipes U Suter EM Shooter 1992 Human peripheral myelin protein-22 carries the L2/HNK-1 carbohydrate adhesion epitope J Neurochem 61 5 1961 1964 10.1111/j.1471-4159.1993.tb09840.x Snipes GJ, Suter U, Shooter EM (1992) Human peripheral myelin protein-22 carries the L2/HNK-1 carbohydrate adhesion epitope. J Neurochem 61(5):1961–1964
98. 99. JD Verrier P Lau L Hudson AK Murashov R Renne L Notterpek 2009 Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a Glia 57 1265 1279 19170179 10.1002/glia.20846 Verrier JD, Lau P, Hudson L, Murashov AK, Renne R, Notterpek L (2009) Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a. Glia 57:1265–1279
99. 100. JP Magyar R Martini T Ruelicke A Aguzzi K Adlkofer Z Dembic J Zielasek KV Toyka U Suter 1996 Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage J Neurosci 16 5351 5360 8757248 1:CAS:528:DyaK28Xlt1eju7k%3D Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adlkofer K, Dembic Z, Zielasek J, Toyka KV, Suter U (1996) Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 16:5351–5360
100. 101. AM Robertson C Huxley RH King PK Thomas 1999 Development of early postnatal peripheral nerve abnormalities in Trembler-J and PMP22 transgenic mice J Anat 195 Pt 3 331 339 10580849 10.1046/j.1469-7580.1999.19530331.x Robertson AM, Huxley C, King RH, Thomas PK (1999) Development of early postnatal peripheral nerve abnormalities in Trembler-J and PMP22 transgenic mice. J Anat 195(Pt 3):331–339
101. 102. S Niemann MW Sereda U Suter IR Griffiths KA Nave 2000 Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22 J Neurosci 20 4120 4128 10818147 1:CAS:528:DC%2BD3cXjsFelur0%3D Niemann S, Sereda MW, Suter U, Griffiths IR, Nave KA (2000) Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22. J Neurosci 20:4120–4128
102. 103. Z Sahenk C Serrano-Munuera L Chen I Kakabadze HN Najagara 2003 Evidence for impaired axonal regeneration in PMP22 duplication: studies in nerve xenografts J Peripher Nerv Syst 8 116 127 12795716 10.1046/j.1529-8027.2003.03017.x Sahenk Z, Serrano-Munuera C, Chen L, Kakabadze I, Najagara HN (2003) Evidence for impaired axonal regeneration in PMP22 duplication: studies in nerve xenografts. J Peripher Nerv Syst 8:116–127
103. 104. MM Schuierer CJ Mann H Bildsoe C Huxley SM Hughes 2005 Analyses of the differentiation potential of satellite cells from myoD−/−, mdx, and PMP22 C22 mice BMC Musculoskelet Disord 6 15 15762989 10.1186/1471-2474-6-15 1:CAS:528:DC%2BD2MXivFyntL4%3D Schuierer MM, Mann CJ, Bildsoe H, Huxley C, Hughes SM (2005) Analyses of the differentiation potential of satellite cells from myoD−/−, mdx, and PMP22 C22 mice. BMC Musculoskelet Disord 6:15
104. 105. K Adlkofer R Martini A Aguzzi J Zielasek KV Toyka U Suter 1995 Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice Nat Genet 11 274 280 7581450 1:CAS:528:DyaK2MXptlSjs7o%3D 10.1038/ng1195-274 Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV, Suter U (1995) Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice. Nat Genet 11:274–280
105. 106. LD Attardi EE Reczek C Cosmas EG Demicco ME McCurrach SW Lowe T Jacks 2000 PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family Genes Dev 14 704 718 10733530 1:CAS:528:DC%2BD3cXisVShu7Y%3D Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW, Jacks T (2000) PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 14:704–718
106. 107. RA Ihrie E Reczek JS Horner L Khachatrian J Sage T Jacks LD Attardi 2003 Perp is a mediator of p53-dependent apoptosis in diverse cell types Curr Biol 13 1985 1990 14614825 1:CAS:528:DC%2BD3sXptVeru70%3D 10.1016/j.cub.2003.10.055 Ihrie RA, Reczek E, Horner JS, Khachatrian L, Sage J, Jacks T, Attardi LD (2003) Perp is a mediator of p53-dependent apoptosis in diverse cell types. Curr Biol 13:1985–1990
107. 108. M Nowak C Koster M Hammerschmidt 2005 Perp is required for tissue-specific cell survival during zebrafish development Cell Death Differ 12 52 64 15529176 1:CAS:528:DC%2BD2cXhtVGmtb3J 10.1038/sj.cdd.4401519 Nowak M, Koster C, Hammerschmidt M (2005) Perp is required for tissue-specific cell survival during zebrafish development. Cell Death Differ 12:52–64
108. 109. M Nestler U Martin P Hortschansky HP Saluz A Henke T Munder 2006 The zinc containing pro-apoptotic protein siva interacts with the peroxisomal membrane protein pmp22 Mol Cell Biochem 287 147 155 16683188 1:CAS:528:DC%2BD28XmvVaqs7Y%3D 10.1007/s11010-005-9082-6 Nestler M, Martin U, Hortschansky P, Saluz HP, Henke A, Munder T (2006) The zinc containing pro-apoptotic protein siva interacts with the peroxisomal membrane protein pmp22. Mol Cell Biochem 287:147–155
109. 110. SB Jacobs S Basak JI Murray N Pathak LD Attardi 2007 Siva is an apoptosis-selective p53 target gene important for neuronal cell death Cell Death Differ 14 1374 1385 17464332 1:CAS:528:DC%2BD2sXms1Srurs%3D 10.1038/sj.cdd.4402128 Jacobs SB, Basak S, Murray JI, Pathak N, Attardi LD (2007) Siva is an apoptosis-selective p53 target gene important for neuronal cell death. Cell Death Differ 14:1374–1385
110. 111. H Nattkamper H Halfter MR Khazaei T Lohmann B Gess M Eisenacher E Willscher P Young 2009 Varying survival of motoneurons and activation of distinct molecular mechanism in response to altered peripheral myelin protein 22 gene dosage J Neurochem 110 935 946 19493167 10.1111/j.1471-4159.2009.06200.x 1:CAS:528:DC%2BD1MXptlens7Y%3D Nattkamper H, Halfter H, Khazaei MR, Lohmann T, Gess B, Eisenacher M, Willscher E, Young P (2009) Varying survival of motoneurons and activation of distinct molecular mechanism in response to altered peripheral myelin protein 22 gene dosage. J Neurochem 110:935–946
111. 112. BB Roa PJ Dyck HG Marks PF Chance JR Lupski 1993 Dejerine–Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene Nat Genet 5 269 273 8275092 1:CAS:528:DyaK2cXivVKmtQ%3D%3D 10.1038/ng1193-269 Roa BB, Dyck PJ, Marks HG, Chance PF, Lupski JR (1993) Dejerine–Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) gene. Nat Genet 5:269–273
112. 113. A Abe K Nakamura M Kato C Numakura T Honma C Seiwa E Shirahata A Itoh Y Kishikawa K Hayasaka 2010 Compound heterozygous PMP22 deletion mutations causing severe Charcot–Marie–Tooth disease type 1 J Hum Genet 55 771 773 20739940 10.1038/jhg.2010.106 Abe A, Nakamura K, Kato M, Numakura C, Honma T, Seiwa C, Shirahata E, Itoh A, Kishikawa Y, Hayasaka K (2010) Compound heterozygous PMP22 deletion mutations causing severe Charcot–Marie–Tooth disease type 1. J Hum Genet 55:771–773
113. 114. K Al-Thihli T Rudkin N Carson C Poulin S Melancon VM Kaloustian Der 2008 Compound heterozygous deletions of PMP22 causing severe Charcot–Marie–Tooth disease of the Dejerine–Sottas disease phenotype Am J Med Genet A 146A 2412 2416 18698610 10.1002/ajmg.a.32456 Al-Thihli K, Rudkin T, Carson N, Poulin C, Melancon S, Der Kaloustian VM (2008) Compound heterozygous deletions of PMP22 causing severe Charcot–Marie–Tooth disease of the Dejerine–Sottas disease phenotype. Am J Med Genet A 146A:2412–2416
114. 115. MA Saporta I Katona X Zhang HP Roper L McClelland F Macdonald L Brueton J Blake U Suter MM Reilly ME Shy J Li 2011 Neuropathy in a human without the PMP22 gene Arch Neurol 68 814 821 21670407 10.1001/archneurol.2011.110 Saporta MA, Katona I, Zhang X, Roper HP, McClelland L, Macdonald F, Brueton L, Blake J, Suter U, Reilly MM, Shy ME, Li J (2011) Neuropathy in a human without the PMP22 gene. Arch Neurol 68:814–821
115. 116. SA Amici WA Dunn Jr L Notterpek 2007 Developmental abnormalities in the nerves of peripheral myelin protein 22-deficient mice J Neurosci Res 85 238 249 17131416 1:CAS:528:DC%2BD2sXhsFakt7s%3D 10.1002/jnr.21118 Amici SA, Dunn WA Jr, Notterpek L (2007) Developmental abnormalities in the nerves of peripheral myelin protein 22-deficient mice. J Neurosci Res 85:238–249
116. 117. K Adlkofer R Frei DH Neuberg J Zielasek KV Toyka U Suter 1997 Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy J Neurosci 17 4662 4671 9169527 1:CAS:528:DyaK2sXjvFCktr4%3D Adlkofer K, Frei R, Neuberg DH, Zielasek J, Toyka KV, Suter U (1997) Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci 17:4662–4671
117. 118. SA Amici WA Dunn Jr AJ Murphy NC Adams NW Gale DM Valenzuela GD Yancopoulos L Notterpek 2006 Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina J Neurosci 26 1179 1189 16436605 1:CAS:528:DC%2BD28XhsVSjsbk%3D 10.1523/JNEUROSCI.2618-05.2006 Amici SA, Dunn WA Jr, Murphy AJ, Adams NC, Gale NW, Valenzuela DM, Yancopoulos GD, Notterpek L (2006) Peripheral myelin protein 22 is in complex with alpha6beta4 integrin, and its absence alters the Schwann cell basal lamina. J Neurosci 26:1179–1189
118. 119. PJ Dyck EH Lambert 1968 Lower motor and primary sensory neuron diseases with peroneal muscular atrophy: I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies Arch Neurol 18 603 618 4297451 1:STN:280:DyaF1c3ntlyrtQ%3D%3D 10.1001/archneur.1968.00470360025002 Dyck PJ, Lambert EH (1968) Lower motor and primary sensory neuron diseases with peroneal muscular atrophy: I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 18:603–618
119. 120. Li J, Lewis R, Shy M (2003) Charcot–Marie–Tooth disease. In: Aminoff M, Daroff R (eds)Encyclopedia of the Neurological Sciences. Academic Press Waltham, MA, USA, pp. 676–686
120. 121. MM Reilly SM Murphy M Laura 2011 Charcot–Marie–Tooth disease J Peripher Nerv Syst 16 1 14 21504497 10.1111/j.1529-8027.2011.00324.x Reilly MM, Murphy SM, Laura M (2011) Charcot–Marie–Tooth disease. J Peripher Nerv Syst 16:1–14
121. 122. A Patzko ME Shy 2011 Update on Charcot–Marie–Tooth disease Curr Neurol Neurosci Rep 11 78 88 21080241 1:CAS:528:DC%2BC3MXjtVShug%3D%3D 10.1007/s11910-010-0158-7 Patzko A, Shy ME (2011) Update on Charcot–Marie–Tooth disease. Curr Neurol Neurosci Rep 11:78–88
122. 123. JR Lupski 1992 An inherited DNA rearrangement and gene dosage effect are responsible for the most common autosomal dominant peripheral neuropathy: Charcot–Marie–Tooth disease type 1A Clin Res 40 645 652 1486731 1:STN:280:DyaK3s7jslGhtA%3D%3D Lupski JR (1992) An inherited DNA rearrangement and gene dosage effect are responsible for the most common autosomal dominant peripheral neuropathy: Charcot–Marie–Tooth disease type 1A. Clin Res 40:645–652
123. 124. U Suter JJ Moskow AA Welcher GJ Snipes B Kosaras RL Sidman AM Buchberg EM Shooter 1992 A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse Proc Natl Acad Sci U S A 89 4382 4386 1374899 1:CAS:528:DyaK38XktVGntrc%3D 10.1073/pnas.89.10.4382 Suter U, Moskow JJ, Welcher AA, Snipes GJ, Kosaras B, Sidman RL, Buchberg AM, Shooter EM (1992) A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse. Proc Natl Acad Sci U S A 89:4382–4386
124. 125. P Raeymaekers V Timmerman E Nelis W Hul Van P Jonghe De JJ Martin C Broeckhoven Van 1992 Estimation of the size of the chromosome 17p11.2 duplication in Charcot–Marie–Tooth neuropathy type 1a (CMT1a). HMSN Collaborative Research Group J Med Genet 29 5 11 1552545 1:STN:280:DyaK383gtlaqsQ%3D%3D 10.1136/jmg.29.1.5 Raeymaekers P, Timmerman V, Nelis E, Van Hul W, De Jonghe P, Martin JJ, Van Broeckhoven C (1992) Estimation of the size of the chromosome 17p11.2 duplication in Charcot–Marie–Tooth neuropathy type 1a (CMT1a). HMSN Collaborative Research Group. J Med Genet 29:5–11
125. 126. M Sereda I Griffiths A Puhlhofer H Stewart MJ Rossner F Zimmerman JP Magyar A Schneider E Hund HM Meinck U Suter KA Nave 1996 A transgenic rat model of Charcot–Marie–Tooth disease Neuron 16 1049 1060 8630243 1:CAS:528:DyaK28XjsVKgsLk%3D 10.1016/S0896-6273(00)80128-2 Sereda M, Griffiths I, Puhlhofer A, Stewart H, Rossner MJ, Zimmerman F, Magyar JP, Schneider A, Hund E, Meinck HM, Suter U, Nave KA (1996) A transgenic rat model of Charcot–Marie–Tooth disease. Neuron 16:1049–1060
126. 127. C Huxley E Passage AM Robertson B Youl S Huston A Manson D Saberan-Djoniedi D Figarella-Branger JF Pellissier PK Thomas M Fontes 1998 Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice Hum Mol Genet 7 449 458 9467003 1:CAS:528:DyaK1cXitFWmt7w%3D 10.1093/hmg/7.3.449 Huxley C, Passage E, Robertson AM, Youl B, Huston S, Manson A, Saberan-Djoniedi D, Figarella-Branger D, Pellissier JF, Thomas PK, Fontes M (1998) Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 7:449–458
127. 128. GA Nicholson LJ Valentijn AK Cherryson ML Kennerson TL Bragg RM DeKroon DA Ross JD Pollard JG McLeod PA Bolhuis 1994 A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies Nat Genet 6 263 266 8012388 1:CAS:528:DyaK2cXivFWitbs%3D 10.1038/ng0394-263 Nicholson GA, Valentijn LJ, Cherryson AK, Kennerson ML, Bragg TL, DeKroon RM, Ross DA, Pollard JD, McLeod JG, Bolhuis PA (1994) A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies. Nat Genet 6:263–266
128. 129. J Li K Ghandour D Radovanovic RR Shy KM Krajewski ME Shy GA Nicholson 2007 Stoichiometric alteration of PMP22 protein determines the phenotype of HNPP Arch Neurol 64 974 978 17620487 10.1001/archneur.64.7.974 Li J, Ghandour K, Radovanovic D, Shy RR, Krajewski KM, Shy ME, Nicholson GA (2007) Stoichiometric alteration of PMP22 protein determines the phenotype of HNPP. Arch Neurol 64:974–978
129. 130. PK Thomas W Marques Jr MB Davis MG Sweeney RH King JL Bradley JR Muddle J Tyson S Malcolm AE Harding 1997 The phenotypic manifestations of chromosome 17p11.2 duplication Brain 120 Pt 3 465 478 9126058 10.1093/brain/120.3.465 Thomas PK, Marques W Jr, Davis MB, Sweeney MG, King RH, Bradley JL, Muddle JR, Tyson J, Malcolm S, Harding AE (1997) The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 120(Pt 3):465–478
130. 131. K Krajewski C Turansky R Lewis J Garbern S Hinderer J Kamholz ME Shy 1999 Correlation between weakness and axonal loss in patients with CMT1A Ann N Y Acad Sci 883 490 492 10586281 1:STN:280:DC%2BD3c%2Flt1Ohug%3D%3D 10.1111/j.1749-6632.1999.tb08618.x Krajewski K, Turansky C, Lewis R, Garbern J, Hinderer S, Kamholz J, Shy ME (1999) Correlation between weakness and axonal loss in patients with CMT1A. Ann N Y Acad Sci 883:490–492
131. 132. RA Lewis AJ Sumner ME Shy 2000 Electrophysiological features of inherited demyelinating neuropathies: a reappraisal in the era of molecular diagnosis Muscle Nerve 23 1472 1487 11003782 1:CAS:528:DC%2BD3cXntlylt7o%3D 10.1002/1097-4598(200010)23:10<1472::AID-MUS3>3.0.CO;2-# Lewis RA, Sumner AJ, Shy ME (2000) Electrophysiological features of inherited demyelinating neuropathies: a reappraisal in the era of molecular diagnosis. Muscle Nerve 23:1472–1487
132. 133. JR Lupski RM Oca-Luna S Slaugenhaupt L Pentao V Guzzetta BJ Trask O Saucedo-Cardenas DF Barker JM Killian CA Garcia 1991 DNA duplication associated with Charcot–Marie–Tooth disease type 1A Cell 66 219 232 1677316 1:CAS:528:DyaK3MXltVOlsbg%3D 10.1016/0092-8674(91)90613-4 Lupski JR, Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA (1991) DNA duplication associated with Charcot–Marie–Tooth disease type 1A. Cell 66:219–232
133. 134. KM Krajewski RA Lewis DR Fuerst C Turansky SR Hinderer J Garbern J Kamholz ME Shy 2000 Neurological dysfunction and axonal degeneration in Charcot–Marie–Tooth disease type 1A Brain 123 Pt 7 1516 1527 10869062 10.1093/brain/123.7.1516 Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, Kamholz J, Shy ME (2000) Neurological dysfunction and axonal degeneration in Charcot–Marie–Tooth disease type 1A. Brain 123(Pt 7):1516–1527
134. 135. A Gabreels-Festen RV Wetering 1999 Human nerve pathology caused by different mutational mechanisms of the PMP22 gene Ann N Y Acad Sci 883 336 343 10586258 1:CAS:528:DyaK1MXns1Cqsr0%3D 10.1111/j.1749-6632.1999.tb08595.x Gabreels-Festen A, Wetering RV (1999) Human nerve pathology caused by different mutational mechanisms of the PMP22 gene. Ann N Y Acad Sci 883:336–343
135. 136. AA Gabreels-Festen PA Bolhuis JE Hoogendijk LJ Valentijn EJ Eshuis FJ Gabreels 1995 Charcot–Marie–Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations Acta Neuropathol 90 645 649 8615087 1:STN:280:DyaK287ptFOltg%3D%3D 10.1007/BF00318579 Gabreels-Festen AA, Bolhuis PA, Hoogendijk JE, Valentijn LJ, Eshuis EJ, Gabreels FJ (1995) Charcot–Marie–Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol 90:645–649
136. 137. AM Robertson RH King JR Muddle PK Thomas 1997 Abnormal Schwann cell/axon interactions in the Trembler-J mouse J Anat 190 Pt 3 423 432 9147228 10.1046/j.1469-7580.1997.19030423.x Robertson AM, King RH, Muddle JR, Thomas PK (1997) Abnormal Schwann cell/axon interactions in the Trembler-J mouse. J Anat 190(Pt 3):423–432
137. 138. V Timmerman P Raeymaekers P Jonghe De G Winter De L Swerts K Jacobs J Gheuens JJ Martin A Vandenberghe C Broeckhoven Van 1990 Assignment of the Charcot–Marie–Tooth neuropathy type 1 (CMT 1a) gene to 17p11.2–p12 Am J Hum Genet 47 680 685 2220808 1:CAS:528:DyaK3MXhtlOjtbs%3D Timmerman V, Raeymaekers P, De Jonghe P, De Winter G, Swerts L, Jacobs K, Gheuens J, Martin JJ, Vandenberghe A, Van Broeckhoven C (1990) Assignment of the Charcot–Marie–Tooth neuropathy type 1 (CMT 1a) gene to 17p11.2–p12. Am J Hum Genet 47:680–685
138. 139. L Pentao CA Wise AC Chinault PI Patel JR Lupski 1992 Charcot–Marie–Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit Nat Genet 2 292 300 1303282 1:CAS:528:DyaK3sXpsFeqtA%3D%3D 10.1038/ng1292-292 Pentao L, Wise CA, Chinault AC, Patel PI, Lupski JR (1992) Charcot–Marie–Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat Genet 2:292–300
139. 140. LT Reiter T Murakami T Koeuth L Pentao DM Muzny RA Gibbs JR Lupski 1996 A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element Nat Genet 12 288 297 8589720 1:CAS:528:DyaK28XhvVSgtLk%3D 10.1038/ng0396-288 Reiter LT, Murakami T, Koeuth T, Pentao L, Muzny DM, Gibbs RA, Lupski JR (1996) A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet 12:288–297
140. 141. BO Choi NK Kim SW Park YS Hyun HJ Jeon JH Hwang KW Chung 2011 Inheritance of Charcot–Marie–Tooth disease 1A with rare nonrecurrent genomic rearrangement Neurogenetics 12 51 58 21193943 1:CAS:528:DC%2BC3MXht1yrs7Y%3D 10.1007/s10048-010-0272-3 Choi BO, Kim NK, Park SW, Hyun YS, Jeon HJ, Hwang JH, Chung KW (2011) Inheritance of Charcot–Marie–Tooth disease 1A with rare nonrecurrent genomic rearrangement. Neurogenetics 12:51–58
141. 142. RA Lewis AJ Sumner 1982 The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies Neurology 32 592 596 6283420 1:STN:280:DyaL383itVCgsw%3D%3D 10.1212/WNL.32.6.592 Lewis RA, Sumner AJ (1982) The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology 32:592–596
142. 143. H Bostock TA Sears RM Sherratt 1981 The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres J Physiol 313 301 315 7277221 1:CAS:528:DyaL3MXktVWit7w%3D Bostock H, Sears TA, Sherratt RM (1981) The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres. J Physiol 313:301–315
143. 144. H Bostock TA Sears 1976 Continuous conduction in demyelinated mammalian nerve fibers Nature 263 786 787 995194 1:STN:280:DyaE2s%2Fls1eqsw%3D%3D 10.1038/263786a0 Bostock H, Sears TA (1976) Continuous conduction in demyelinated mammalian nerve fibers. Nature 263:786–787
144. 145. H Bostock RM Sherratt TA Sears 1978 Overcoming conduction failure in demyelinated nerve fibres by prolonging action potentials Nature 274 385 387 209331 1:STN:280:DyaE1c3itlGkuw%3D%3D 10.1038/274385a0 Bostock H, Sherratt RM, Sears TA (1978) Overcoming conduction failure in demyelinated nerve fibres by prolonging action potentials. Nature 274:385–387
145. 146. M Rasminsky TA Sears 1971 Internodal conduction in normal and demyelinated mammalian single nerve fibres J Physiol 217 66P 67P 5571952 Rasminsky M, Sears TA (1971) Internodal conduction in normal and demyelinated mammalian single nerve fibres. J Physiol 217:66P–67P
146. 147. S Lafontaine M Rasminsky T Saida AJ Sumner 1982 Conduction block in rat myelinated fibres following acute exposure to anti-galactocerebroside serum J Physiol 323 287 306 7097575 1:STN:280:DyaL383ktFKrtQ%3D%3D Lafontaine S, Rasminsky M, Saida T, Sumner AJ (1982) Conduction block in rat myelinated fibres following acute exposure to anti-galactocerebroside serum. J Physiol 323:287–306
147. 148. MH Brill SG Waxman JW Moore RW Joyner 1977 Conduction velocity and spike configuration in myelinated fibers: computed dependence on internode distance J Neurol Neurosurg Psychiatry 40 769 774 925697 1:STN:280:DyaE1c%2FkslGlsA%3D%3D 10.1136/jnnp.40.8.769 Brill MH, Waxman SG, Moore JW, Joyner RW (1977) Conduction velocity and spike configuration in myelinated fibers: computed dependence on internode distance. J Neurol Neurosurg Psychiatry 40:769–774
148. 149. FA Court DL Sherman T Pratt EM Garry RR Ribchester DF Cottrell SM Fleetwood-Walker PJ Brophy 2004 Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves Nature 431 191 195 15356632 1:CAS:528:DC%2BD2cXntlGks74%3D 10.1038/nature02841 Court FA, Sherman DL, Pratt T, Garry EM, Ribchester RR, Cottrell DF, Fleetwood-Walker SM, Brophy PJ (2004) Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves. Nature 431:191–195
149. 150. Saporta MA, Katona I, Lewis RA, Masse S, Shy ME, Li J (2009) Shortened internodal length of dermal myelinated nerve fibres in Charcot–Marie–Tooth disease type 1A. Brain 132:3263–72
150. 151. J Fortun JD Verrier JC Go I Madorsky WA Dunn L Notterpek 2007 The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones Neurobiol Dis 25 252 265 17174099 1:CAS:528:DC%2BD2sXpvVKmtQ%3D%3D 10.1016/j.nbd.2006.09.018 Fortun J, Verrier JD, Go JC, Madorsky I, Dunn WA, Notterpek L (2007) The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones. Neurobiol Dis 25:252–265
151. 152. J Fortun WA Dunn Jr S Joy J Li L Notterpek 2003 Emerging role for autophagy in the removal of aggresomes in Schwann cells J Neurosci 23 10672 10680 14627652 1:CAS:528:DC%2BD3sXpsFGjurc%3D Fortun J, Dunn WA Jr, Joy S, Li J, Notterpek L (2003) Emerging role for autophagy in the removal of aggresomes in Schwann cells. J Neurosci 23:10672–10680
152. 153. J Fortun JC Go J Li SA Amici WA Dunn Jr L Notterpek 2006 Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression Neurobiol Dis 22 153 164 16326107 1:CAS:528:DC%2BD28XivVOjtL0%3D 10.1016/j.nbd.2005.10.010 Fortun J, Go JC, Li J, Amici SA, Dunn WA Jr, Notterpek L (2006) Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol Dis 22:153–164
153. 154. S Rangaraju JD Verrier I Madorsky J Nicks WA Dunn Jr L Notterpek 2010 Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice J Neurosci 30 11388 11397 20739560 1:CAS:528:DC%2BC3cXhtFens7bE 10.1523/JNEUROSCI.1356-10.2010 Rangaraju S, Verrier JD, Madorsky I, Nicks J, Dunn WA Jr, Notterpek L (2010) Rapamycin activates autophagy and improves myelination in explant cultures from neuropathic mice. J Neurosci 30:11388–11397
154. 155. CO Hanemann D D'Urso AA Gabreels-Festen HW Muller 2000 Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot–Marie–Tooth type 1A Brain 123 Pt 5 1001 1006 10775544 10.1093/brain/123.5.1001 Hanemann CO, D'Urso D, Gabreels-Festen AA, Muller HW (2000) Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot–Marie–Tooth type 1A. Brain 123(Pt 5):1001–1006
155. 156. G Giambonini-Brugnoli J Buchstaller L Sommer U Suter N Mantei 2005 Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation Neurobiol Dis 18 656 668 15755691 1:CAS:528:DC%2BD2MXhvFyntrs%3D 10.1016/j.nbd.2004.10.023 Giambonini-Brugnoli G, Buchstaller J, Sommer L, Suter U, Mantei N (2005) Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation. Neurobiol Dis 18:656–668
156. 157. T Vigo L Nobbio PV Hummelen M Abbruzzese G Mancardi N Verpoorten K Verhoeven MW Sereda KA Nave V Timmerman A Schenone 2005 Experimental Charcot–Marie–Tooth type 1A: a cDNA microarrays analysis Mol Cell Neurosci 28 703 714 15797717 1:CAS:528:DC%2BD2MXis1GrtLY%3D 10.1016/j.mcn.2004.11.016 Vigo T, Nobbio L, Hummelen PV, Abbruzzese M, Mancardi G, Verpoorten N, Verhoeven K, Sereda MW, Nave KA, Timmerman V, Schenone A (2005) Experimental Charcot–Marie–Tooth type 1A: a cDNA microarrays analysis. Mol Cell Neurosci 28:703–714
157. 158. L Nobbio L Sturla F Fiorese C Usai G Basile I Moreschi F Benvenuto E Zocchi FA De A Schenone S Bruzzone 2009 P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy J Biol Chem 284 23146 23158 19546221 1:CAS:528:DC%2BD1MXpvFKiu7k%3D 10.1074/jbc.M109.027128 Nobbio L, Sturla L, Fiorese F, Usai C, Basile G, Moreschi I, Benvenuto F, Zocchi E, De FA, Schenone A, Bruzzone S (2009) P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy. J Biol Chem 284:23146–23158
158. 159. G Saher S Quintes W Mobius MC Wehr EM Kramer-Albers B Brugger KA Nave 2009 Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction J Neurosci 29 6094 6104 19439587 1:CAS:528:DC%2BD1MXmt1Cmtbs%3D 10.1523/JNEUROSCI.0686-09.2009 Saher G, Quintes S, Mobius W, Wehr MC, Kramer-Albers EM, Brugger B, Nave KA (2009) Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction. J Neurosci 29:6094–6104
159. 160. MT Berciano E Calle R Fernandez M Lafarga 1998 Regulation of Schwann cell numbers in tellurium-induced neuropathy: apoptosis, supernumerary cells and internodal shortening Acta Neuropathol 95 269 279 9542592 1:CAS:528:DyaK1cXhtVOktbc%3D 10.1007/s004010050797 Berciano MT, Calle E, Fernandez R, Lafarga M (1998) Regulation of Schwann cell numbers in tellurium-induced neuropathy: apoptosis, supernumerary cells and internodal shortening. Acta Neuropathol 95:269–279
160. 161. R Fledrich B Schlotter-Weigel TJ Schnizer SP Wichert RM Stassart GM zu Horste A Klink BG Weiss U Haag MC Walter B Rautenstrauss W Paulus MJ Rossner MW Sereda 2012 A rat model of Charcot–Marie–Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients Brain 135 72 87 22189569 10.1093/brain/awr322 Fledrich R, Schlotter-Weigel B, Schnizer TJ, Wichert SP, Stassart RM, zu Horste GM, Klink A, Weiss BG, Haag U, Walter MC, Rautenstrauss B, Paulus W, Rossner MJ, Sereda MW (2012) A rat model of Charcot–Marie–Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients. Brain 135:72–87
161. 162. Kinter J, Lazzati T, Schmid D, Zeis T, Erne B, Lutzelschwab R, Steck AJ, Pareyson D, Peles E, Schaeren-Wiemers N (2012) An essential role of MAG in mediating axon-myelin attachment in Charcot–Marie–Tooth 1A disease. Neurobiol Dis 49C:221–231
162. 163. PF Chance MK Alderson KA Leppig MW Lensch N Matsunami B Smith PD Swanson SJ Odelberg CM Disteche TD Bird 1993 DNA deletion associated with hereditary neuropathy with liability to pressure palsies Cell 72 143 151 8422677 1:CAS:528:DyaK3sXnvVGktA%3D%3D 10.1016/0092-8674(93)90058-X Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Disteche CM, Bird TD (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72:143–151
163. 164. ME Shy MT Scavina A Clark KM Krajewski J Li J Kamholz E Kolodny K Szigeti RA Fischer GM Saifi SS Scherer JR Lupski 2006 T118M PMP22 mutation causes partial loss of function and HNPP-like neuropathy Ann Neurol 59 358 364 16437560 1:CAS:528:DC%2BD28XhvVSksLw%3D 10.1002/ana.20777 Shy ME, Scavina MT, Clark A, Krajewski KM, Li J, Kamholz J, Kolodny E, Szigeti K, Fischer RA, Saifi GM, Scherer SS, Lupski JR (2006) T118M PMP22 mutation causes partial loss of function and HNPP-like neuropathy. Ann Neurol 59:358–364
164. 165. PM Gonnaud F Sturtz Y Fourbil C Bonnebouche C Tranchant JM Warter G Chazot B Bady C Vial AS Brechard 1995 DNA analysis as a tool to confirm the diagnosis of asymptomatic hereditary neuropathy with liability to pressure palsies (HNPP) with further evidence for the occurrence of de novo mutations Acta Neurol Scand 92 313 318 8848937 1:STN:280:DyaK287ht1yrsw%3D%3D 10.1111/j.1600-0404.1995.tb00135.x Gonnaud PM, Sturtz F, Fourbil Y, Bonnebouche C, Tranchant C, Warter JM, Chazot G, Bady B, Vial C, Brechard AS (1995) DNA analysis as a tool to confirm the diagnosis of asymptomatic hereditary neuropathy with liability to pressure palsies (HNPP) with further evidence for the occurrence of de novo mutations. Acta Neurol Scand 92:313–318
165. 166. P Mouton S Tardieu R Gouider N Birouk T Maisonobe O Dubourg A Brice E LeGuern P Bouche 1999 Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion Neurology 52 1440 1446 10227632 1:STN:280:DyaK1M3kt1Wksw%3D%3D 10.1212/WNL.52.7.1440 Mouton P, Tardieu S, Gouider R, Birouk N, Maisonobe T, Dubourg O, Brice A, LeGuern E, Bouche P (1999) Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology 52:1440–1446
166. 167. J Li K Krajewski RA Lewis ME Shy 2004 Loss-of-function phenotype of hereditary neuropathy with liability to pressure palsies Muscle Nerve 29 205 210 14755484 10.1002/mus.10521 Li J, Krajewski K, Lewis RA, Shy ME (2004) Loss-of-function phenotype of hereditary neuropathy with liability to pressure palsies. Muscle Nerve 29:205–210
167. 168. P Mandich R James S Nassani R Defferrari E Bellone G Mancardi A Schenone M Abbruzzese M Rocchi F Ajmar 1995 Molecular diagnosis of hereditary neuropathy with liability to pressure palsies (HNPP) by detection of 17p11.2 deletion in Italian patients J Neurol 242 295 298 7643137 1:STN:280:DyaK2MzntVynuw%3D%3D 10.1007/BF00878871 Mandich P, James R, Nassani S, Defferrari R, Bellone E, Mancardi G, Schenone A, Abbruzzese M, Rocchi M, Ajmar F (1995) Molecular diagnosis of hereditary neuropathy with liability to pressure palsies (HNPP) by detection of 17p11.2 deletion in Italian patients. J Neurol 242:295–298
168. 169. V Timmerman A Lofgren E Guern Le P Liang P Jonghe De JJ Martin D Verhalle W Robberecht R Gouider A Brice C Broeckhoven Van 1996 Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP) Hum Genet 97 26 34 8557256 1:CAS:528:DyaK28Xht1antLo%3D 10.1007/BF00218828 Timmerman V, Lofgren A, Le Guern E, Liang P, De Jonghe P, Martin JJ, Verhalle D, Robberecht W, Gouider R, Brice A, Van Broeckhoven C (1996) Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP). Hum Genet 97:26–34
169. 170. J Li K Krajewski ME Shy RA Lewis 2002 Hereditary neuropathy with liability to pressure palsy: the electrophysiology fits the name Neurology 58 1769 1773 12084875 10.1212/WNL.58.12.1769 Li J, Krajewski K, Shy ME, Lewis RA (2002) Hereditary neuropathy with liability to pressure palsy: the electrophysiology fits the name. Neurology 58:1769–1773
170. 171. SH Horowitz LE Spollen W Yu 2004 Hereditary neuropathy with liability to pressure palsy: fulminant development with axonal loss during military training J Neurol Neurosurg Psychiatry 75 1629 1631 15489403 1:STN:280:DC%2BD2crhvVKisg%3D%3D 10.1136/jnnp.2003.029314 Horowitz SH, Spollen LE, Yu W (2004) Hereditary neuropathy with liability to pressure palsy: fulminant development with axonal loss during military training. J Neurol Neurosurg Psychiatry 75:1629–1631
171. 172. PF Chance MW Lensch H Lipe RH Brown Sr RH Brown Jr TD Bird 1994 Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: two distinct genetic disorders Neurology 44 2253 2257 7991108 1:STN:280:DyaK2M%2FotlWjsA%3D%3D 10.1212/WNL.44.12.2253 Chance PF, Lensch MW, Lipe H, Brown RH Sr, Brown RH Jr, Bird TD (1994) Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: two distinct genetic disorders. Neurology 44:2253–2257
172. 173. AA Amato GS Gronseth KJ Callerame KS Kagan-Hallet WW Bryan RJ Barohn 1996 Tomaculous neuropathy: a clinical and electrophysiological study in patients with and without 1.5-Mb deletions in chromosome 17p11.2 Muscle Nerve 19 16 22 8538664 1:STN:280:DyaK287itFWiuw%3D%3D 10.1002/(SICI)1097-4598(199601)19:1<16::AID-MUS3>3.0.CO;2-B Amato AA, Gronseth GS, Callerame KJ, Kagan-Hallet KS, Bryan WW, Barohn RJ (1996) Tomaculous neuropathy: a clinical and electrophysiological study in patients with and without 1.5-Mb deletions in chromosome 17p11.2. Muscle Nerve 19:16–22
173. 174. CJ Earl PM Fullerton GS Wakefield HS Schutta 1964 Hereditary neuropathy, with liability to pressure palsies; a clinical and electrophysiological study of four families Q J Med 33 481 498 14212604 1:STN:280:DyaF2M%2Fhs12qtA%3D%3D Earl CJ, Fullerton PM, Wakefield GS, Schutta HS (1964) Hereditary neuropathy, with liability to pressure palsies; a clinical and electrophysiological study of four families. Q J Med 33:481–498
174. 175. F Stogbauer P Young G Kuhlenbaumer P Jonghe De V Timmerman 2000 Hereditary recurrent focal neuropathies: clinical and molecular features Neurology 54 546 551 10680781 1:CAS:528:DC%2BD3cXht1aktL4%3D 10.1212/WNL.54.3.546 Stogbauer F, Young P, Kuhlenbaumer G, De Jonghe P, Timmerman V (2000) Hereditary recurrent focal neuropathies: clinical and molecular features. Neurology 54:546–551
175. 176. PB Andersson E Yuen K Parko YT So 2000 Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies Neurology 54 40 44 10636123 1:STN:280:DC%2BD3c7gtVSkug%3D%3D 10.1212/WNL.54.1.40 Andersson PB, Yuen E, Parko K, So YT (2000) Electrodiagnostic features of hereditary neuropathy with liability to pressure palsies. Neurology 54:40–44
176. 177. R Madrid G Bradley 1975 The pathology of neuropathies with focal thickening of the myelin sheath (tomaculous neuropathy): studies on the formation of the abnormal myelin sheath J Neurol Sci 25 415 448 10.1016/0022-510X(75)90263-4 Madrid R, Bradley G (1975) The pathology of neuropathies with focal thickening of the myelin sheath (tomaculous neuropathy): studies on the formation of the abnormal myelin sheath. J Neurol Sci 25:415–448
177. 178. Y Bai X Zhang I Katona MA Saporta ME Shy HA O'Malley LL Isom U Suter J Li 2010 Conduction block in PMP22 deficiency J Neurosci 30 600 608 20071523 1:CAS:528:DC%2BC3cXhtFaht7g%3D 10.1523/JNEUROSCI.4264-09.2010 Bai Y, Zhang X, Katona I, Saporta MA, Shy ME, O'Malley HA, Isom LL, Suter U, Li J (2010) Conduction block in PMP22 deficiency. J Neurosci 30:600–608
178. 179. S Sander RA Ouvrier JG McLeod GA Nicholson JD Pollard 2000 Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies J Neurol Neurosurg Psychiatry 68 483 488 10727485 1:STN:280:DC%2BD3c7ptlOhsA%3D%3D 10.1136/jnnp.68.4.483 Sander S, Ouvrier RA, McLeod JG, Nicholson GA, Pollard JD (2000) Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies. J Neurol Neurosurg Psychiatry 68:483–488
179. 180. Z Cai P Sutton-Smith J Swift K Cash J Finnie A Turnley PD Thompson PC Blumbergs 2002 Tomacula in MAG-deficient mice J Peripher Nerv Syst 7 181 189 12365566 10.1046/j.1529-8027.2002.02023.x Cai Z, Sutton-Smith P, Swift J, Cash K, Finnie J, Turnley A, Thompson PD, Blumbergs PC (2002) Tomacula in MAG-deficient mice. J Peripher Nerv Syst 7:181–189
180. 181. Z Cai PC Blumbergs K Cash PJ Rice J Manavis J Swift MN Ghabriel PD Thompson 2006 Paranodal pathology in Tangier disease with remitting–relapsing multifocal neuropathy J Clin Neurosci 13 492 497 16678735 1:STN:280:DC%2BD28zksV2mtQ%3D%3D 10.1016/j.jocn.2005.07.009 Cai Z, Blumbergs PC, Cash K, Rice PJ, Manavis J, Swift J, Ghabriel MN, Thompson PD (2006) Paranodal pathology in Tangier disease with remitting–relapsing multifocal neuropathy. J Clin Neurosci 13:492–497
181. 182. Z Cai JW Finnie PC Blumbergs J Manavis MN Ghabriel PD Thompson 2006 Early paranodal myelin swellings (tomacula) in an avian riboflavin deficiency model of demyelinating neuropathy Exp Neurol 198 65 71 16336963 1:CAS:528:DC%2BD28Xhs1SnsrY%3D 10.1016/j.expneurol.2005.10.028 Cai Z, Finnie JW, Blumbergs PC, Manavis J, Ghabriel MN, Thompson PD (2006) Early paranodal myelin swellings (tomacula) in an avian riboflavin deficiency model of demyelinating neuropathy. Exp Neurol 198:65–71
182. 183. A Bolino A Bolis SC Previtali G Dina S Bussini G Dati S Amadio U Carro Del DD Mruk ML Feltri CY Cheng A Quattrini L Wrabetz 2004 Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis J Cell Biol 167 711 721 15557122 1:CAS:528:DC%2BD2cXhtVaqtb3M 10.1083/jcb.200407010 Bolino A, Bolis A, Previtali SC, Dina G, Bussini S, Dati G, Amadio S, Del Carro U, Mruk DD, Feltri ML, Cheng CY, Quattrini A, Wrabetz L (2004) Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J Cell Biol 167:711–721
183. 184. Bird TD (1993) Charcot–Marie–Tooth neuropathy type 1 Gene Reviews
184. 185. M Russo M Laura JM Polke MB Davis J Blake S Brandner RA Hughes H Houlden DL Bennett MP Lunn MM Reilly 2011 Variable phenotypes are associated with PMP22 missense mutations Neuromuscul Disord 21 106 114 21194947 1:STN:280:DC%2BC3M7ivFOluw%3D%3D 10.1016/j.nmd.2010.11.011 Russo M, Laura M, Polke JM, Davis MB, Blake J, Brandner S, Hughes RA, Houlden H, Bennett DL, Lunn MP, Reilly MM (2011) Variable phenotypes are associated with PMP22 missense mutations. Neuromuscul Disord 21:106–114
185. 186. B Gess A Jeibmann A Schirmacher I Kleffner M Schilling P Young 2011 Report of a novel mutation in the PMP22 gene causing an axonal neuropathy Muscle Nerve 43 605 609 21337347 10.1002/mus.21973 Gess B, Jeibmann A, Schirmacher A, Kleffner I, Schilling M, Young P (2011) Report of a novel mutation in the PMP22 gene causing an axonal neuropathy. Muscle Nerve 43:605–609
186. 187. BB Roa CA Garcia JR Lupski 1991 Charcot–Marie–Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy Int J Neurol 25–26 97 107 11980069 Roa BB, Garcia CA, Lupski JR (1991) Charcot–Marie–Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy. Int J Neurol 25–26:97–107
187. 188. PI Patel BB Roa AA Welcher R Schoener-Scott BJ Trask L Pentao GJ Snipes CA Garcia U Francke EM Shooter JR Lupski U Suter 1992 The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot–Marie–Tooth disease type 1A Nat Genet 1 159 165 1303228 1:CAS:528:DyaK3sXitFSlsLg%3D 10.1038/ng0692-159 Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, Snipes GJ, Garcia CA, Francke U, Shooter EM, Lupski JR, Suter U (1992) The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot–Marie–Tooth disease type 1A. Nat Genet 1:159–165
188. 189. JJ Devaux SS Scherer 2005 Altered ion channels in an animal model of Charcot–Marie–Tooth disease type IA J Neurosci 25 1470 1480 15703401 1:CAS:528:DC%2BD2MXhs1Kmu7s%3D 10.1523/JNEUROSCI.3328-04.2005 Devaux JJ, Scherer SS (2005) Altered ion channels in an animal model of Charcot–Marie–Tooth disease type IA. J Neurosci 25:1470–1480
189. 190. H Nodera M Nishimura EL Logigian DN Herrmann R Kaji 2003 HNPP due to a novel missense mutation of the PMP22 gene Neurology 60 1863 1864 12796555 10.1212/01.WNL.0000066049.13848.F2 Nodera H, Nishimura M, Logigian EL, Herrmann DN, Kaji R (2003) HNPP due to a novel missense mutation of the PMP22 gene. Neurology 60:1863–1864
190. 191. MJ Kovach JP Lin S Boyadjiev K Campbell L Mazzeo K Herman LA Rimer W Frank B Llewellyn EW Jabs D Gelber VE Kimonis 1999 A unique point mutation in the PMP22 gene is associated with Charcot–Marie–Tooth disease and deafness Am J Hum Genet 64 1580 1593 10330345 1:CAS:528:DyaK1MXltlOgtbo%3D 10.1086/302420 Kovach MJ, Lin JP, Boyadjiev S, Campbell K, Mazzeo L, Herman K, Rimer LA, Frank W, Llewellyn B, Jabs EW, Gelber D, Kimonis VE (1999) A unique point mutation in the PMP22 gene is associated with Charcot–Marie–Tooth disease and deafness. Am J Hum Genet 64:1580–1593
191. 192. S Bort E Nelis V Timmerman T Sevilla A Cruz-Martinez F Martinez JM Millan J Arpa JJ Vilchez F Prieto C Broeckhoven Van F Palau 1997 Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot–Marie–Tooth disease and hereditary neuropathy with liability to pressure palsies Hum Genet 99 746 754 9187667 1:CAS:528:DyaK2sXjvVCru7k%3D 10.1007/s004390050442 Bort S, Nelis E, Timmerman V, Sevilla T, Cruz-Martinez A, Martinez F, Millan JM, Arpa J, Vilchez JJ, Prieto F, Van Broeckhoven C, Palau F (1997) Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot–Marie–Tooth disease and hereditary neuropathy with liability to pressure palsies. Hum Genet 99:746–754
192. 194. PP Lenssen AA Gabreels-Festen LJ Valentijn PJ Jongen SE Beersum van BG Engelen van PJ Wensen van PA Bolhuis FJ Gabreels EC Mariman 1998 Hereditary neuropathy with liability to pressure palsies. Phenotypic differences between patients with the common deletion and a PMP22 frame shift mutation Brain 121 Pt 8 1451 1458 9712007 10.1093/brain/121.8.1451 Lenssen PP, Gabreels-Festen AA, Valentijn LJ, Jongen PJ, van Beersum SE, van Engelen BG, van Wensen PJ, Bolhuis PA, Gabreels FJ, Mariman EC (1998) Hereditary neuropathy with liability to pressure palsies. Phenotypic differences between patients with the common deletion and a PMP22 frame shift mutation. Brain 121(Pt 8):1451–1458
193. 195. M Luigetti A Conte F Madia ML Mereu M Zollino G Marangi MG Pomponi G Liberatore PA Tonali M Sabatelli 2008 A new single-nucleotide deletion of PMP22 in an HNPP family without recurrent palsies Muscle Nerve 38 1060 1064 18642376 1:CAS:528:DC%2BD1cXhtVegtb3K 10.1002/mus.21083 Luigetti M, Conte A, Madia F, Mereu ML, Zollino M, Marangi G, Pomponi MG, Liberatore G, Tonali PA, Sabatelli M (2008) A new single-nucleotide deletion of PMP22 in an HNPP family without recurrent palsies. Muscle Nerve 38:1060–1064
194. 196. U Suter AA Welcher T Ozcelik GJ Snipes B Kosaras U Francke S Billings-Gagliardi RL Sidman EM Shooter 1992 Trembler mouse carries a point mutation in a myelin gene Nature 356 241 244 1552943 1:CAS:528:DyaK3sXhvVClsbc%3D 10.1038/356241a0 Suter U, Welcher AA, Ozcelik T, Snipes GJ, Kosaras B, Francke U, Billings-Gagliardi S, Sidman RL, Shooter EM (1992) Trembler mouse carries a point mutation in a myelin gene. Nature 356:241–244
195. 197. PA Low 1976 Hereditary hypertrophic neuropathy in the trembler mouse: Part 1. Histopathological studies: light microscopy J Neurol Sci 30 327 341 187739 1:STN:280:DyaE2s%2Fntleqtw%3D%3D 10.1016/0022-510X(76)90138-6 Low PA (1976) Hereditary hypertrophic neuropathy in the trembler mouse: Part 1. Histopathological studies: light microscopy. J Neurol Sci 30:327–341
196. 198. PA Low 1976 Hereditary hypertrophic neuropathy in the trembler mouse: Part 2. Histopathological studies: electron microscopy J Neurol Sci 30 343 368 187740 1:STN:280:DyaE2s%2FntleqtA%3D%3D 10.1016/0022-510X(76)90139-8 Low PA (1976) Hereditary hypertrophic neuropathy in the trembler mouse: Part 2. Histopathological studies: electron microscopy. J Neurol Sci 30:343–368
197. 199. LJ Valentijn F Baas RA Wolterman JE Hoogendijk NH Bosch van den I Zorn AW Gabreels-Festen M Visser de PA Bolhuis 1992 Identical point mutations of PMP-22 in Trembler-J mouse and Charcot–Marie–Tooth disease type 1A Nat Genet 2 288 291 1303281 1:CAS:528:DyaK3sXltlKktLc%3D 10.1038/ng1292-288 Valentijn LJ, Baas F, Wolterman RA, Hoogendijk JE, van den Bosch NH, Zorn I, Gabreels-Festen AW, de Visser M, Bolhuis PA (1992) Identical point mutations of PMP-22 in Trembler-J mouse and Charcot–Marie–Tooth disease type 1A. Nat Genet 2:288–291
198. 200. VV Ionasescu R Ionasescu C Searby DF Barker 1993 Charcot–Marie–Tooth neuropathy type 1A with both duplication and non-duplication Hum Mol Genet 2 405 410 8099303 1:CAS:528:DyaK3sXktVKgur8%3D 10.1093/hmg/2.4.405 Ionasescu VV, Ionasescu R, Searby C, Barker DF (1993) Charcot–Marie–Tooth neuropathy type 1A with both duplication and non-duplication. Hum Mol Genet 2:405–410
199. 201. AM Isaacs 2000 Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy Hum Mol Genet 9 1865 1871 10915775 1:CAS:528:DC%2BD3cXlsFOqu7g%3D 10.1093/hmg/9.12.1865 Isaacs AM et al (2000) Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy. Hum Mol Genet 9:1865–1871
200. 202. MC Ryan EM Shooter L Notterpek 2002 Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations Neurobiol Dis 10 109 118 12127149 1:CAS:528:DC%2BD38XltFyrtbw%3D 10.1006/nbdi.2002.0500 Ryan MC, Shooter EM, Notterpek L (2002) Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. Neurobiol Dis 10:109–118
201. 203. I Madorsky K Opalach A Waber JD Verrier C Solmo T Foster WA Dunn Jr L Notterpek 2009 Intermittent fasting alleviates the neuropathic phenotype in a mouse model of Charcot–Marie–Tooth disease Neurobiol Dis 34 146 154 19320048 1:CAS:528:DC%2BD1MXjsVOgu7w%3D 10.1016/j.nbd.2009.01.002 Madorsky I, Opalach K, Waber A, Verrier JD, Solmo C, Foster T, Dunn WA Jr, Notterpek L (2009) Intermittent fasting alleviates the neuropathic phenotype in a mouse model of Charcot–Marie–Tooth disease. Neurobiol Dis 34:146–154
202. 204. G Rosso C Negreira JR Sotelo A Kun 2012 Myelinating and demyelinating phenotype of Trembler-J mouse (a model of Charcot–Marie–Tooth human disease) analyzed by atomic force microscopy and confocal microscopy J Mol Recognit 25 247 255 22528185 1:CAS:528:DC%2BC38XmtVKhtb4%3D 10.1002/jmr.2176 Rosso G, Negreira C, Sotelo JR, Kun A (2012) Myelinating and demyelinating phenotype of Trembler-J mouse (a model of Charcot–Marie–Tooth human disease) analyzed by atomic force microscopy and confocal microscopy. J Mol Recognit 25:247–255
203. 205. A Kun L Canclini G Rosso M Bresque C Romeo A Hanusz K Cal A Calliari SJ Sotelo JR Sotelo 2012 F-actin distribution at nodes of Ranvier and Schmidt–Lanterman incisures in mammalian sciatic nerves Cytoskeleton (Hoboken) 69 486 495 1:CAS:528:DC%2BC38XpvVeiu7Y%3D 10.1002/cm.21011 Kun A, Canclini L, Rosso G, Bresque M, Romeo C, Hanusz A, Cal K, Calliari A, Sotelo SJ, Sotelo JR (2012) F-actin distribution at nodes of Ranvier and Schmidt–Lanterman incisures in mammalian sciatic nerves. Cytoskeleton (Hoboken) 69:486–495
204. 206. A Fontanini R Chies EL Snapp M Ferrarini GM Fabrizi C Brancolini 2005 Glycan-independent role of calnexin in the intracellular retention of Charcot–Marie–Tooth 1A Gas3/PMP22 mutants J Biol Chem 280 2378 2387 15537650 1:CAS:528:DC%2BD2MXksVWlsQ%3D%3D 10.1074/jbc.M405104200 Fontanini A, Chies R, Snapp EL, Ferrarini M, Fabrizi GM, Brancolini C (2005) Glycan-independent role of calnexin in the intracellular retention of Charcot–Marie–Tooth 1A Gas3/PMP22 mutants. J Biol Chem 280:2378–2387
205. 207. R Naef U Suter 1999 Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies Neurobiol Dis 6 1 14 10078969 1:CAS:528:DyaK1MXhslymt74%3D 10.1006/nbdi.1998.0227 Naef R, Suter U (1999) Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies. Neurobiol Dis 6:1–14
206. 208. C Huxley E Passage A Manson G Putzu D Figarella-Branger JF Pellissier M Fontes 1996 Construction of a mouse model of Charcot–Marie–Tooth disease type 1A by pronuclear injection of human YAC DNA Hum Mol Genet 5 563 569 8733121 1:CAS:528:DyaK28XivVOjsbk%3D 10.1093/hmg/5.5.563 Huxley C, Passage E, Manson A, Putzu G, Figarella-Branger D, Pellissier JF, Fontes M (1996) Construction of a mouse model of Charcot–Marie–Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 5:563–569
207. 209. A Robaglia-Schlupp J Pizant JC Norreel E Passage D Saberan-Djoneidi JL Ansaldi L Vinay D Figarella-Branger N Levy F Clarac P Cau JF Pellissier M Fontes 2002 PMP22 overexpression causes dysmyelination in mice Brain 125 2213 2221 12244079 1:STN:280:DC%2BD38nhs1GisQ%3D%3D 10.1093/brain/awf230 Robaglia-Schlupp A, Pizant J, Norreel JC, Passage E, Saberan-Djoneidi D, Ansaldi JL, Vinay L, Figarella-Branger D, Levy N, Clarac F, Cau P, Pellissier JF, Fontes M (2002) PMP22 overexpression causes dysmyelination in mice. Brain 125:2213–2221
208. 210. Perea J, Robertson A, Tolmachova T, Muddle J, King RH, Ponsford S, Thomas PK, Huxley C (2001) Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 10:1007–18
209. 211. C Verhamme RH King AL Asbroek ten JR Muddle M Nourallah R Wolterman F Baas IN Schaik van 2011 Myelin and axon pathology in a long-term study of PMP22-overexpressing mice J Neuropathol Exp Neurol 70 386 398 21487305 1:CAS:528:DC%2BC3MXkvF2isbs%3D 10.1097/NEN.0b013e318217eba0 Verhamme C, King RH, ten Asbroek AL, Muddle JR, Nourallah M, Wolterman R, Baas F, van Schaik IN (2011) Myelin and axon pathology in a long-term study of PMP22-overexpressing mice. J Neuropathol Exp Neurol 70:386–398
210. 212. EW Henry JS Cowen RL Sidman 1983 Comparison of Trembler and Trembler-J mouse phenotypes: varying severity of peripheral hypomyelination J Neuropathol Exp Neurol 42 688 706 6313869 1:STN:280:DyaL2c%2FjsFahtg%3D%3D 10.1097/00005072-198311000-00008 Henry EW, Cowen JS, Sidman RL (1983) Comparison of Trembler and Trembler-J mouse phenotypes: varying severity of peripheral hypomyelination. J Neuropathol Exp Neurol 42:688–706
211. 213. F Kaya S Belin P Bourgeois J Micaleff O Blin M Fontes 2007 Ascorbic acid inhibits PMP22 expression by reducing cAMP levels Neuromuscul Disord 17 248 253 17303424 10.1016/j.nmd.2006.12.008 Kaya F, Belin S, Bourgeois P, Micaleff J, Blin O, Fontes M (2007) Ascorbic acid inhibits PMP22 expression by reducing cAMP levels. Neuromuscul Disord 17:248–253
212. 214. F Kaya S Belin G Diamantidis M Fontes 2008 Ascorbic acid is a regulator of the intracellular cAMP concentration: old molecule, new functions? FEBS Lett 582 3614 3618 18835269 1:CAS:528:DC%2BD1cXht12rt7%2FN 10.1016/j.febslet.2008.09.040 Kaya F, Belin S, Diamantidis G, Fontes M (2008) Ascorbic acid is a regulator of the intracellular cAMP concentration: old molecule, new functions? FEBS Lett 582:3614–3618
213. 215. MB Clark MB Bunge 1989 Cultured Schwann cells assemble normal-appearing basal lamina only when they ensheathe axons Dev Biol 133 393 404 2659405 1:STN:280:DyaL1M3ns1Kqsw%3D%3D 10.1016/0012-1606(89)90043-2 Clark MB, Bunge MB (1989) Cultured Schwann cells assemble normal-appearing basal lamina only when they ensheathe axons. Dev Biol 133:393–404
214. 216. RP Bunge MB Bunge M Bates 1989 Movements of the Schwann cell nucleus implicate progression of the inner (axon-related) Schwann cell process during myelination J Cell Biol 109 273 284 2745552 1:STN:280:DyaL1MzgvVyltQ%3D%3D 10.1083/jcb.109.1.273 Bunge RP, Bunge MB, Bates M (1989) Movements of the Schwann cell nucleus implicate progression of the inner (axon-related) Schwann cell process during myelination. J Cell Biol 109:273–284
215. 217. MW Sereda HG Meyer zu U Suter N Uzma KA Nave 2003 Therapeutic administration of progesterone antagonist in a model of Charcot–Marie–Tooth disease (CMT-1A) Nat Med 9 1533 1537 14608378 1:CAS:528:DC%2BD3sXpt1Gksrg%3D 10.1038/nm957 Sereda MW, Meyer zu HG, Suter U, Uzma N, Nave KA (2003) Therapeutic administration of progesterone antagonist in a model of Charcot–Marie–Tooth disease (CMT-1A). Nat Med 9:1533–1537
216. 218. D Pareyson MM Reilly A Schenone GM Fabrizi T Cavallaro L Santoro G Vita A Quattrone L Padua F Gemignani F Visioli M Laura D Radice D Calabrese RA Hughes A Solari 2011 Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial Lancet Neurol 10 320 328 21393063 1:CAS:528:DC%2BC3MXjs12jtLk%3D 10.1016/S1474-4422(11)70025-4 Pareyson D, Reilly MM, Schenone A, Fabrizi GM, Cavallaro T, Santoro L, Vita G, Quattrone A, Padua L, Gemignani F, Visioli F, Laura M, Radice D, Calabrese D, Hughes RA, Solari A (2011) Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol 10:320–328
217. 219. I Katona X Wu SM Feely S Sottile CE Siskind LJ Miller ME Shy J Li 2009 PMP22 expression in dermal nerve myelin from patients with CMT1A Brain 132 1734 1740 19447823 10.1093/brain/awp113 Katona I, Wu X, Feely SM, Sottile S, Siskind CE, Miller LJ, Shy ME, Li J (2009) PMP22 expression in dermal nerve myelin from patients with CMT1A. Brain 132:1734–1740
218. 220. RC Melcangi V Magnaghi I Cavarretta I Zucchi P Bovolin D D'Urso L Martini 1999 Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action J Neurosci Res 56 349 357 10340743 1:CAS:528:DyaK1MXjtVans7o%3D 10.1002/(SICI)1097-4547(19990515)56:4<349::AID-JNR3>3.0.CO;2-H Melcangi RC, Magnaghi V, Cavarretta I, Zucchi I, Bovolin P, D'Urso D, Martini L (1999) Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action. J Neurosci Res 56:349–357
219. 221. Horste MG, Nave KA, Sereda MW (2004) PMP22 expression in skin biopsies serves as a marker for disease severity in a model of Charcot–Marie–Tooth disease 1A (CMT1A)
220. 222. HG Meyer zu T Prukop D Liebetanz W Mobius KA Nave MW Sereda 2007 Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy Ann Neurol 61 61 72 10.1002/ana.21026 1:CAS:528:DC%2BD2sXitlyjtLw%3D Meyer zu HG, Prukop T, Liebetanz D, Mobius W, Nave KA, Sereda MW (2007) Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Ann Neurol 61:61–72
221. 223. ME Egan M Pearson SA Weiner V Rajendran D Rubin J Glockner-Pagel S Canny K Du GL Lukacs MJ Caplan 2004 Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects Science 304 600 602 15105504 1:CAS:528:DC%2BD2cXjt1Crsrs%3D 10.1126/science.1093941 Egan ME, Pearson M, Weiner SA, Rajendran V, Rubin D, Glockner-Pagel J, Canny S, Du K, Lukacs GL, Caplan MJ (2004) Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 304:600–602
222. 224. M Khajavi K Shiga W Wiszniewski F He CA Shaw J Yan TG Wensel GJ Snipes JR Lupski 2007 Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy Am J Hum Genet 81 438 453 17701891 1:CAS:528:DC%2BD2sXhtVSqur3L 10.1086/519926 Khajavi M, Shiga K, Wiszniewski W, He F, Shaw CA, Yan J, Wensel TG, Snipes GJ, Lupski JR (2007) Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy. Am J Hum Genet 81:438–453
223. 225. G Saher B Brugger C Lappe-Siefke W Mobius R Tozawa MC Wehr F Wieland S Ishibashi KA Nave 2005 High cholesterol level is essential for myelin membrane growth Nat Neurosci 8 468 475 15793579 1:CAS:528:DC%2BD2MXis1Orur8%3D Saher G, Brugger B, Lappe-Siefke C, Mobius W, Tozawa R, Wehr MC, Wieland F, Ishibashi S, Nave KA (2005) High cholesterol level is essential for myelin membrane growth. Nat Neurosci 8:468–475
224. 226. KJ Smith SM Hall 1988 Peripheral demyelination and remyelination initiated by the calcium-selective ionophore ionomycin: in vivo observations J Neurol Sci 83 37 53 3126271 1:CAS:528:DyaL1cXht12mtb4%3D 10.1016/0022-510X(88)90018-4 Smith KJ, Hall SM (1988) Peripheral demyelination and remyelination initiated by the calcium-selective ionophore ionomycin: in vivo observations. J Neurol Sci 83:37–53
225. 227. KJ Smith R Kapoor SM Hall M Davies 2001 Electrically active axons degenerate when exposed to nitric oxide Ann Neurol 49 470 476 11310624 1:CAS:528:DC%2BD3MXjtVyjtL0%3D 10.1002/ana.96 Smith KJ, Kapoor R, Hall SM, Davies M (2001) Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 49:470–476
226. 228. Z Sahenk L Chen JR Mendell 1999 Effects of PMP22 duplication and deletions on the axonal cytoskeleton Ann Neurol 45 16 24 9894872 1:CAS:528:DyaK1MXhtV2jsLw%3D 10.1002/1531-8249(199901)45:1<16::AID-ART5>3.0.CO;2-F Sahenk Z, Chen L, Mendell JR (1999) Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol 45:16–24
227. 229. N Liu S Varma EM Shooter RJ Tolwani 2005 Enhancement of Schwann cell myelin formation by K252a in the Trembler-J mouse dorsal root ganglion explant culture J Neurosci Res 79 310 317 15605381 1:CAS:528:DC%2BD2MXhtVWgu78%3D 10.1002/jnr.20357 Liu N, Varma S, Shooter EM, Tolwani RJ (2005) Enhancement of Schwann cell myelin formation by K252a in the Trembler-J mouse dorsal root ganglion explant culture. J Neurosci Res 79:310–317